| (+/-)-Nicotine |
22083-74-5 |
Nicotine |
Nicotinic Acetylcholine Receptor Agonist |
X |
|
|
|
|
|
| (5Z)-7-Oxozeaenol |
66018-38-0 |
|
TAK1 MAPKKK Inhibitor |
X |
X |
|
|
|
|
| (D,L)-Mevalonic Acid Lactone |
674-26-0 |
DL-Mevalonic Acid Lactone; Mevalonolactone |
HMG-CoA Reductase Inhibitor |
X |
|
|
|
|
|
| (R,S)-Tocopherol |
10191-41-0 |
Vitamin E |
Antioxidant |
X |
|
|
|
|
|
| (S)-FTY720 Phosphate |
402616-26-6 |
|
S1P Receptor Agonist |
X |
|
|
|
|
|
| (S)-Reticuline |
|
Reticuline |
Alkaloid |
X |
|
|
|
|
|
| (S)-Reticuline 3-O-sulfate |
|
|
CNS Depressant |
X |
|
|
|
|
|
| (S)-Reticuline 7-O-sulfate |
|
|
CNS Depressant |
X |
|
|
|
|
|
| 15(R)-Prostaglandin D2 |
59894-05-2 |
PGD2 |
DP Agonist |
X |
|
|
|
|
|
| 17α-Ethynylestradiol |
57-63-6 |
17alpha-Ethynylestradiol |
ER Agonist |
X |
|
|
|
|
|
| 17β-Estradiol |
50-28-2 |
Estradiol |
ER Agonist |
X |
|
|
|
|
|
| 1-Methyl-L-Tryptophan |
21339-55-9 |
|
IDO Inhibitor |
X |
|
|
|
|
|
| 2-(N-Ethylperfluorooctanesulfonamido)acetic Acid |
2991-50-6 |
EtFOSAA, N-Ethylperfluorooctanesulfonamidoacetate, Et-PFOSA-AcOH |
Endocrine disruptor that interferes with nuclear receptor signaling and lipid metabolism |
X |
|
|
|
|
New – 2025 |
| 22(R)-Hydroxycholesterol |
17954-98-2 |
|
LXRα Agonist |
X |
X |
|
|
|
|
| 24(S)-Hydroxycholesterol |
474-73-7 |
Cerebrosterol |
LXRα Agonist |
X |
|
|
|
|
|
| 25-Hydroxyvitamin D3 |
19356-17-3 |
25(OH)D; Calcidiol; Calcifediol |
Vitamin D Receptor (VDR) Agonist |
X |
|
|
|
|
|
| 2-Chloroethyl Ethyl Sulfide |
693-07-2 |
Sulfur Mustard |
Vesicant |
X |
|
|
|
|
|
| 2-Cl-IB-MECA |
163042-96-4 |
C-Ibza-MU; Cl-IB-MECA |
Adenosine A3 Receptor Agonist |
X |
|
|
|
|
|
| 2-Iodomelatonin |
|
|
Melatonin Receptor Agonist |
X |
|
|
|
|
|
| 2-Methoxyestradiol |
362-07-2 |
2-methoxy-17beta-estradiol |
Microtubule Disruptor |
X |
|
|
|
|
|
| 4-Aminobenzoic Acid |
150-13-0 |
PABA; p-Aminobenzoic Acid |
Vitamin B Complex Member |
X |
|
|
|
|
|
| 5-Aminolevulinic Acid Hydrochloride |
|
|
Photosensitizer Precursor |
X |
|
|
|
|
|
| 5a-POPC |
|
|
Cholesterol Efflux Promoter |
X |
|
|
|
|
|
| 5-ASA |
89-57-6 |
Apriso; Asacol; Canasa; Delzicol; Mesalazine; Mezavant; Pentasa; Rowasa; Salofalk |
15-Lipoxygenase Inhibitor; COX1/2 Inhibitor; IKK1/2 Inhibitor |
X |
|
|
|
|
|
| 5a-SM |
|
5A-sphingomyelin |
Cholesterol Efflux Promoter |
X |
|
|
|
|
|
| 666-15 |
1433286-70-4 |
|
CREB Inhibitor |
X |
|
|
|
|
|
| 6-Mercaptopurine |
6112-76-1 |
|
Purine Nucleotide Synthesis Inhibitor |
X |
|
|
|
|
|
| 6-Thioguanine |
154-42-7 |
2-Amino-6-mercaptopurine; 6-Mercaptoguanine; Thioguanine; Tioguanine |
Antineoplastic Agent |
X |
|
|
|
|
|
| 8-Azaguanine |
134-58-7 |
Azaguanine; Guanazol; Guanazolo |
Purine Nucleotide Synthesis Inhibitor; Xanthine Oxidase Inhibitor |
X |
|
|
|
|
|
| 8-Br-cAMP |
23583-48-4 |
8-Bromoadenosine; BCAMP |
PKA Activator |
X |
|
|
|
|
|
| 8-CPT-cAMP |
93882-12-3 |
Rp-Cpt-camps |
PKA Activator; PKG Activator |
X |
|
|
|
|
|
| 8-Hydroxyquinoline |
148-24-3 |
8-Quinolinol |
Lipophilic metal chelator |
X |
|
|
|
|
New – 2025 |
| 8-Prenylnaringenin |
|
(S)-8-dimethylallylnaringenin; 8-PN; Flavaprenin; Hopein |
Phytoestrogen; ER Agonist |
X |
|
|
|
|
|
| 9-Chlorohexadecafluoro-3-oxanone-1-sulfonic Acid |
73606-19-6 |
Potassium salt, C8 Cl-PFESA, 6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate, 6:2 Chlorinated Polyfluoroalkyl Ether Sulfonic Acid, 6:2 Cl-PFAES, 6:2 Cl-PFESA, 9Cl-PF3ONS |
Endocrine disruptor that interferes with estrogen receptors and induces thyroid gland follicular hyperplasia. |
X |
|
|
|
|
New – 2025 |
| 9-cis-Retinoic Acid |
|
|
RAR/RXR Agonist |
X |
|
|
|
|
|
| A 205804 |
251992-66-2 |
|
E-selectin/ICAM-1 Inhibitor |
X |
|
|
|
|
|
| A23187 |
52665-69-7 |
Antibiotic A23187; Calcimycin; Ionophore A23187 |
Calcium Ionophore |
X |
|
|
|
|
|
| A939572 |
1032229-3-6 |
SCD1 Inhibitor |
Stearoyl-CoA Desaturase 1 Inhibitor |
X |
|
|
X |
|
|
| Abacavir Sulfate |
188062-50-2 |
Abacavir; Epzicom; Ziagen |
Nucleoside Analog Reverse-transcriptase Inhibitor (NRTI) |
X |
|
|
|
|
|
| Abatacept |
|
Orencia |
T Cell Costimulation Modulator |
X |
|
|
|
|
|
| ABBV-744 |
2138861-99-9 |
|
BRD Inhibitor |
X |
|
|
|
X |
|
| Abemaciclib |
1231930-82-7 |
LY2835219; Verzenio |
CDK Inhibitor |
X |
|
|
|
|
|
| Abiraterone |
154229-19-3 |
CB-7598 |
CYP17A1 Inhibitor |
X |
|
|
|
|
|
| Abiraterone Acetate |
154229-18-2 |
CB-7630; CB7630; Zytiga |
Cytochrome P450 17A1 Inhibitor |
X |
|
|
|
|
|
| Abitrexate |
59-05-2 |
Methotrexate |
Tetrahydrofolate Dehydrogenase Inhbitor |
X |
|
|
|
|
|
| Abrocitinib |
1622902-68-4 |
PF-04965842 |
JAK1 Inhibitor |
X |
|
|
|
|
|
| Acarbose |
56180-94-0 |
Glucobay; Precose |
Maltase-glucoamylase Inhibitor; Pancreatic α-amylase Inhibitor |
X |
|
|
|
|
|
| ACBI1 |
2375564-55-7 |
|
SMARCA2, SMARCA4 and PBRM1 degrader |
X |
|
|
|
|
|
| ACBI2 |
2913161-19-8 |
|
VHL PROTAC SMARCA2 degrader |
X |
|
|
|
|
|
| Acebutolol Hydrochloride |
34381-68-5 |
Sectral |
β1 Adrenergic Receptor Inhibitor |
X |
|
|
|
|
|
| Acemetacin |
53164-05-9 |
Acemetacinum; Acemix; Emflex; Rantudil |
NSAID |
X |
|
|
|
|
|
| Acetaminophen |
103-90-2 |
4-Acetamidophenol; APAP; Paracetamol |
COX-2 Inhibitor |
X |
|
|
|
|
|
| Acetic Acid |
64-19-7 |
Glacial Acetic Acid |
Solvent |
X |
|
|
|
|
|
| Acetonitrile |
75-05-8 |
Cyanomethane; Ethanenitrile; Methyl cyanide |
Organic Solvent |
X |
|
|
|
|
|
| Acitretin |
55079-83-9 |
Ro 10-1670; Ro 10-1670/000; all-trans-Acitretin |
Retinoid |
X |
|
|
|
|
|
| Acriflavin |
8048-52-0 |
Flavine; Panflavin |
Antimicrobial Agent |
X |
|
|
|
|
|
| Actinomycin D |
50-76-0 |
Cosmegen; Dactinomycin |
RNA Polymerase Inhibitor; DNA Inhibitor |
X |
|
|
|
|
|
| Actinonin |
13434-13-4 |
Actinonine; Octanohydroxamic acid |
Peptide Deformylase Inhibitor |
X |
|
|
|
|
|
| Adalimumab |
331731-18-1 |
Humira |
TNFα Inhibitor |
X |
|
|
|
|
|
| Adapalene |
106685-40-9 |
Adaferin; Adapaleno; Adapalenum; Differin |
RAR/RXR Agonist; Vitamin A Derivative; Retinoic Acid Analogue |
X |
|
|
|
|
|
| Adefovir Dipivoxil |
142340-99-6 |
GS-0393; Hepsera; PMEA; Preveon |
Reverse Transcriptase Inhbitor |
X |
|
|
|
|
|
| Adenine |
73-24-5 |
6-Aminopurine |
Nucleobase; Purine Derivative |
X |
|
|
|
|
|
| Adenosine 5-triphosphate Disodium Salt Trihydrate |
34369-07-8 |
ATP disodium salt hydrate |
Metabolite |
X |
|
|
|
|
|
| ADU-S100 |
1638241-89-0 |
2’3’-c-di-AM(PS)2 (Rp,Rp) |
STING Agonist |
X |
|
X |
X |
|
|
| AEB071 |
425637-18-9 |
AEB-071; Sotrastaurin; UNII-7I279E1NZ8 |
PKCΘ Inhibitor |
X |
|
|
|
|
|
| AEG3482 |
63735-71-7 |
|
Hsp90 Inhibitor |
X |
|
|
|
|
|
| Afamelanotide |
75921-69-6 |
Scenesse; melanotan-1 |
Melanocortin Receptor Agonist |
X |
|
|
|
|
|
| Afatinib |
439081-18-2 |
BIBW2992 |
EGFR/HER2 Inhibitor |
X |
|
|
|
|
|
| AG1478 |
153436-53-4 |
AG-1478; Tyrphostin AG 1478 |
EGFR Inhibitor |
X |
|
|
|
|
|
| AIM-100 |
|
|
Ack1 Inhibitor |
|
X |
|
|
|
|
| Albendazole |
54965-21-8 |
Albenza |
Microtubule Inhibitor; Anthelmintic Agent |
X |
|
|
|
|
|
| Aldosterone |
52-39-1 |
|
Steroid hormone |
X |
|
|
|
|
New – 2025 |
| Alectinib |
1256580-46-7 |
Alecensa |
ALK Inhibitor |
X |
|
X |
X |
|
|
| Alemtuzumab |
|
Campath; Lemtrada |
Anti-CD52 Antibody |
X |
|
|
|
|
|
| Alendronate |
121268-17-5 |
Fosamax |
Farnesyl Diphosphate Synthase Inhibitor |
X |
|
|
|
|
|
| Alfacalcidol |
41294-56-8 |
1-Hydroxycholecalciferol; Bondiol; Etalpha; Oxydevit; Tevabone |
Vitamin D Analogue |
X |
|
|
|
|
|
| Alprostadil |
745-65-3 |
Alprostadilum; Befar; Caverject; Edex; Prostaglandin E1; Prostin vr |
EP Agonist; Prostanoid Receptor Agonist (EP1, EP2) |
X |
|
|
|
|
|
| Altrenogest |
850-52-2 |
Allyltrenbolone; Allyltrienolone; Matrix, RU-2267; Regulate |
Progesterone Receptor (PR) Agonist; Androgen Receptor Agonist |
X |
|
|
|
|
|
| Altretamine |
645-05-6 |
Hexalen |
Alkylating Antineoplastic Agent |
X |
|
|
|
|
|
| Alverine Citrate |
5560-59-8 |
Oxydevit; Phenpropamine Citrate |
Smooth Muscle Relaxant; 5-HT1A Inhibitor |
X |
|
|
|
|
|
| AM-966 |
1228690-19-4 |
AM966; UNII-CEO54NH393 |
LPA1 Receptor Inhibitor |
X |
X |
|
|
|
|
| AMD3465 |
185991-07-5 |
AMD 3465 Hexahydrobromide |
CXCR4 Inhibitor |
X |
|
X |
|
|
|
| Amfenac Sodium |
61618-27-7 |
2-amino-3-benzoylbenzeneacetic Acid |
NSAID |
X |
|
|
|
|
|
| AMG208 |
1002304-34-8 |
AMG 208; UNII-Y2SR66P7VM |
c-Met Inhibitor |
X |
|
|
|
|
|
| AMG548 |
864249-60-5 |
AMG 548 |
p38 MAPK Inhibitor |
X |
|
|
|
|
|
| AMG-900 |
945595-80-2 |
|
Aurora Kinase Inhibitor |
X |
|
|
|
|
|
| Amifampridine |
|
|
Potassium Channel Blocker |
X |
|
|
|
X |
|
| Aminoglutethimide |
125-84-8 |
Cytadren; NSC 33091 |
Aromatase Inhibitor |
X |
|
|
|
|
|
| Aminophylline |
317-34-0 |
|
PDE Inhibitor; Adenosine Receptor Inhibitor |
X |
|
|
|
|
|
| Amitriptyline Hydrochloride |
549-18-8 |
Elavil |
SNRI; TrkA Agonist; TrkB Agonist; SMase Inhibitor |
X |
|
|
|
|
|
| Amlexanox |
68302-57-8 |
Amlenanox; Amoxanox; Aphthasol; Solfa |
Anti-inflammatory Agent; Antiallergic Agent; Immunomodulating Agent |
X |
|
|
|
|
|
| Amodiaquin |
86-42-0 |
Camochin; Camoquin; Camoquine; Flavoquine |
Antimicrobial Agent |
X |
|
|
|
|
|
| Amphotericin B |
1397-89-3 |
Abelcet; Ambisome; Amphotec |
Antimicrobial Agent |
X |
|
|
|
|
|
| Ampiroxicam |
99464-64-9 |
|
NSAID |
X |
|
|
|
|
|
| Amprenavir |
161814-49-9 |
Agenerase; Prozei; Vertex VX478 |
Protease Inhibitor |
X |
|
|
|
|
|
| Amylin |
122384-88-7 |
|
Peptide agonist for amylin |
X |
|
|
|
|
New – 2025 |
| Anacetrapib |
875446-37-0 |
MK-0859 |
CETP Inhibitor |
X |
|
|
|
|
|
| Anakinra |
143090-92-0 |
ICIL-1RA; IL-1RN; IL-1ra; IL1 Inhibitor; IRAP; Kineret |
IL-1 Receptor Inhibitor |
X |
|
|
|
|
|
| Antazoline Hydrochloride |
2508-72-7 |
Vasocon-a |
H1 Receptor Inhibitor |
X |
|
|
|
|
|
| Antimycin A |
1397-94-0 |
Antimycin A1; Antimycin A1b; Antipiricullin; Fintrol; Virosin |
Cytochrome c Reductase Inhibitor; Mitochondrial Inhibitor |
X |
|
|
|
|
|
| Apelin-13 |
|
|
Apelin Receptor (APJ) Ligand |
X |
|
|
|
|
|
| Apoptolidin |
194874-06-1 |
Apoptosis Activator IV; Nocardiopsis sp. |
F(0)F(1) ATPase Inhibitor; Mitochondrial Inhibitor |
X |
|
|
|
|
|
| Apremilast |
608141-41-9; |
Apremilastum; CC 10004; CC-10004; Otezla |
PDE4 Inhibitor |
X |
|
|
|
|
|
| APX-3330 |
136164-66-4 |
Erenapurstat; E3330 |
Inhibitor of Ape-1/Ref-1 redox |
X |
|
|
|
|
New – 2025 |
| Artemisinin |
63968-64-9 |
NSC 369397 |
Antimicrobial Agent |
X |
|
|
|
|
|
| Articaine Hydrochloride |
23964-57-0 |
Carticaine |
Anesthetic Agent |
X |
|
|
|
|
|
| ARV-825 |
1818885-28-7 |
|
BRD4 PROTAC |
X |
|
|
|
|
|
| AS1892802 |
928320-12-1 |
AS 1892802; AS-1892802 |
ROCK1, ROCK2 Inhibitor |
X |
|
|
|
|
|
| AS2444697 |
|
AKOS027470180 |
IRAK4 Inhibitor |
X |
|
|
|
|
|
| AS601245 |
345987-15-7 |
AS 601245 |
JNK Inhibitor |
X |
|
|
|
|
|
| AS605240 |
648450-29-7 |
PI 3-Kgamma Inhibitor; PI3-Kγ Inhibitor |
PI3K Inhibitor |
X |
|
|
|
|
|
| Asciminib |
1492952-76-7 |
ABL001 |
BCR-ABL1 inhibitor |
X |
|
|
|
|
|
| Asenapine |
85650-56-2 |
|
Antipsychotic Agent |
X |
|
|
|
|
|
| Aspirin |
50-78-2 |
Acetylsalicylate; Acetylsalicylic acid |
COX Inhibitor |
X |
|
|
|
|
|
| Astemizole |
68844-77-9 |
Astemison; Astemizol; Astemizolum |
Antihistamine Agent |
X |
|
|
|
|
|
| Atazanavir Sulfate |
229975-97-7 |
BMS 232632; CGP 73547; Reyataz |
HIV Protease Inhibitor |
X |
|
|
|
|
|
| Atlizumab |
375823-41-9 |
Actemra; MRA; RoActemra; Tocilizumab |
IL-6 Receptor Inhibitor |
X |
|
|
|
|
|
| Atomoxetine Hydrochloride |
82248-59-7 |
Strattera |
Norepinephrine Reuptake Inhibitor |
X |
|
|
|
|
|
| Atorvastatin |
134523-00-5 |
Lipitor; Lipovastatinklonal |
HMG-CoA Reductase Inhibitor |
X |
|
|
|
|
|
| Atovaquone |
95233-18-4 |
Atavaquone |
Cytochrome b Inhibitor |
X |
|
|
|
|
|
| ATP |
|
Adenosine triphosphate |
Coenzyme |
X |
|
|
|
|
|
| Atracurium Besylate |
64228-81-5 |
64228-81-5; Atracurium Besilate; Atracurium Besylate; Tracrium |
Neuromuscular Blocking Agent |
X |
|
|
|
|
|
| Auranofin |
34031-32-8 |
NSC 321521; Ridauragold thiol; SKF 39162 |
Thioredoxin Reductase Inhibitor |
X |
|
|
|
|
|
| Avacopan |
1346623-17-3 |
CCX168 |
Complement 5a receptor Inhibitor |
X |
|
|
|
|
|
| AVL-292 |
|
CC-292; Spebrutinib |
BTK Inhibitor |
X |
|
X |
X |
|
|
| AX-15836 |
2035509-96-5 |
|
ERK5 Inhibitor |
X |
|
|
|
|
|
| Axitinib |
319460-85-0 |
Inlyta |
VEGFR2 Inhibitor |
X |
X |
X |
X |
|
|
| AZ876 |
898800-26-5 |
LPM029_300383_00 |
LXR Agonist |
X |
|
|
|
|
|
| Azaperone |
1649-18-9 |
R-1929; Stresnil; Suicalm |
Dopamine Receptor Inhibitor |
X |
|
|
|
|
|
| Azatadine Dimaleate |
3978-86-7 |
Azatadine Maleate; Bonamid; Idulian |
Histamine and Cholinergic Inhibitor |
X |
|
|
|
|
|
| Azathioprine |
446-86-6 |
Azasan; BW-57-322; Imuran |
Purine Metabolism Anatgonist |
X |
X |
|
|
|
|
| AZD1208 |
1204144-28-4 |
AZD 1208 |
PIM Kinase Inhibitor |
X |
|
|
|
|
|
| AZD4547 |
1035270-39-3 |
AZD 4547; AZD-4547 |
FGFR Inhibitor |
X |
|
|
|
|
|
| AZD8055 |
1009298-09-2 |
AZD 8055; AZD-8055 |
mTOR Inhibitor |
X |
|
|
|
|
|
| Azithromycin |
83905-01-5 |
Azasite; Azenil; Azifast; Azigram; Azimakrol; Hemomycin; Zithromax |
Antibiotic Agent |
X |
X |
|
|
|
|
| Bacitracin Zinc |
1405-89-6 |
|
Antibiotic Agent |
X |
|
|
|
|
|
| Bafilomycin A1 |
88899-55-2 |
NSC 381866 |
V-ATPase Inhibitor |
X |
|
|
|
|
|
| Baricitinib |
1187594-09-7 |
INCB 028050; LY3009104 |
JAK1/2 Inhibitor |
X |
|
|
|
|
|
| BAY 2666605 |
2275774-60-0 |
|
PDE3A/B Inhibitor |
X |
|
|
|
|
|
| BAY-876 |
1799753-84-6 |
|
GLUT1 Inhibitor |
X |
|
|
|
|
|
| BBO-8520 |
2893809-51-1 |
|
Inhibitor targeting KRAS |
X |
|
|
|
|
New – 2025 |
| BDH35145960b |
|
|
BET Inhibitor |
X |
|
|
|
|
|
| BDV0005266b |
|
|
Bromodomain Inhibitor |
X |
|
|
|
|
|
| Beclomethasone Dipropionate |
4419-39-0 |
Qvar |
GR Agonist |
X |
|
|
|
|
|
| Bedaquiline |
|
EX00040046; Sirturo |
Mycobacterial ATP Synthase Inhibitor |
X |
|
|
|
|
|
| Belatacept |
|
|
T Cell Costimulation Modulator |
X |
|
|
|
|
|
| Belimumab |
|
Benlysta |
BAFF Inhibitor |
X |
|
|
|
|
|
| Belinostat |
866323-14-0 |
PXD101; PX105684 |
HDAC Inhibitor |
X |
|
|
|
|
|
| Belumosudil |
911417-87-3 |
KD025 synonym |
selective inhibitor of ROCK2 |
|
X |
|
|
|
New – 2025 |
| Bemcentinib |
1037624-75-1 |
BGB324; R428 |
AXL Inhibitor |
X |
X |
X |
X |
|
|
| Benzethonium Chloride |
121-54-0 |
Antiseptol; BZT; Diapp; Disilyn; Hyamine; Phemithyn; Phermerol; Polymine D; Quatrachlor; Salanine |
Antimicrobial Agent; AChE Inhibitor |
X |
|
|
|
|
|
| Benzocaine |
94-09-7 |
Americaine; Ethyl Aminobenzoate |
Anesthetic |
X |
|
|
|
|
|
| Benztropine Mesylate |
132-17-2 |
Cogentin |
Muscarinic Acetylcholine Receptor (mAChR) Inhibitor |
X |
|
|
|
|
|
| Benzydamine Hydrochloride |
132-69-4 |
AF-864; Tantum |
NSAID |
X |
|
|
|
|
|
| Beraprost |
|
MDL-201229; Procylin |
Prostacyclin Analogue |
X |
|
|
|
|
|
| Berberine |
|
Berberin; Umbellatine |
Dipeptidyl Peptidase IV Inhibitor; PTP1B Inhibitor |
X |
|
|
|
|
|
| Bergapten |
484-20-8 |
5-Methoxypsoralen; Bergaptene; Heraclin; Majudi |
Psoralen |
X |
|
|
|
|
|
| beta-Mercaptoethanol |
|
|
Inorganic Compound |
|
|
X |
X |
|
|
| Betamethasone |
378-44-9 |
Celestone |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Betamethasone Dipropionate |
5593-20-4 |
Diprolene |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Betamethasone Valerate |
2152-44-5 |
Betnovate |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Betamipron |
3440-28-6 |
Benzoyl-beta-alanine |
Carbapenem Antibiotic Agent |
X |
|
|
|
|
|
| Betapar |
1247-42-3 |
Betanisona; Meprednisone; Methylprednisone |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Bevacizumab |
216974-75-3 |
Avastin; anti-VEGF |
VEGFA Inhibitor |
X |
|
X |
|
|
|
| Bexagliflozin |
1118567-05-7 |
EGT-1442, THR-1442 |
Potent and selective SGLT2 inhibitor |
X |
|
|
|
|
New – 2025 |
| BI-10n |
|
|
ITK Inhibitor |
X |
|
|
|
|
|
| BI2536 |
755038-02-9 |
|
BET Inhibitor; PLK1 Inhibitor |
X |
|
X |
|
|
|
| BI-2545 |
2162961-71-7 |
|
Autotaxin Inhibitor |
X |
X |
X |
X |
|
|
| BI-3663 |
2341740-84-7 |
|
PTK2/FAK PROTAC |
X |
|
|
|
|
|
| BI-7273 |
1883429-21-7 |
|
BRD7/9 Inhibitor |
X |
|
|
|
|
|
| BIBX1382 |
196612-93-8 |
BIBX 1382; Falnidamol |
EGFR Inhibitor |
X |
|
|
|
|
|
| Bilirubin |
635-65-4 |
Bilirubin IX- α; Hematoidin; Hemetoidin |
Heme Metabolite |
X |
|
|
|
|
|
| Bindarit |
|
|
CCL2/7/8 Inhibitor |
|
X |
|
|
|
|
| Biperiden Hydrochloride |
1235-82-1 |
Akineton; Akinophyl |
Acetylcholine Inhibitor |
X |
|
|
|
|
|
| Bisacodyl |
603-50-9 |
Bicol; Brocalax; Dulcolax; Durolax |
Laxative |
X |
|
|
|
|
|
| Bismuth Subcitrate Potassium |
880149-29-1 |
Bismuth Subcitrate; Bismuth Subcitrate Potassium; De-Noltab; Gastrodenol; Tripotassium Dicitratobismuthate |
Antibiotic Agent |
X |
|
|
|
|
|
| Bisphenol A |
80-05-7 |
|
Endocrine-disrupting toxicant |
X |
|
|
|
|
New – 2025 |
| Bleomycin Sulfate |
9041-93-4 |
Blenoxane; Bleomycin |
Antineoplastic Agent |
X |
|
|
|
|
|
| BMP7 |
|
Osteogenic Protein-1 (OP-1) |
Activin Receptor Agonist (Activin RIA, RIIA, RIIB; BMPR-IA, BMPR-IB, BMPR-II) |
X |
|
|
|
|
|
| BMS-777607 |
1025720-94-8 |
BMS777607 |
c-Met Inhibitor; Axl Inhibitor; RON Inhibitor; Tyro3 Inhibitor |
X |
X |
X |
|
|
|
| BMS-986365 |
2446928-30-7 |
CC-94676 |
Androgen receptor (AR) PROTAC degrader. |
X |
|
|
|
|
New – 2025 |
| BMY 45778 |
152575-66-1 |
|
Non-prostanoid Prostacyclin IP Receptor Partial Agonist. |
X |
|
|
|
|
|
| Bortezomib |
179324-69-7 |
Velcade |
Proteasome Inhibitor |
X |
X |
|
|
|
|
| Bosentan |
147536-97-8 |
Bosentan Hydrate; Bosentanum; Tracleer |
ET-A Inhibitor; ET-B Inhibitor |
X |
|
|
|
|
|
| Bosutinib |
380843-75-4 |
Bosulif; SKI-606 |
BCR-ABL Inhibitor; Src Inhibitor |
X |
X |
|
X |
|
|
| Branaplam |
1562338-42-4 |
LMI070; NVS-SM1 |
survival motor neuron-2 splicing modulator |
X |
|
|
|
|
New – 2025 |
| Brefeldin A |
20350-15-6 |
Ascotoxin; Cyanein; Decumbin; Synergisidin |
ARF1 Inhibitor |
X |
|
|
|
|
|
| Brequinar |
|
Bay_BioMAP_005_B2; bipenquinate |
DHODH Inhibitor |
X |
|
|
|
|
|
| Brigatinib |
|
|
ALK Inhibitor; EGFR Inhibitor |
|
|
X |
X |
|
|
| Bromfenac Sodium |
91714-93-1 |
Xibrom |
NSAID; COX Inhibitor |
X |
|
|
|
|
|
| Bromosporine |
1619994-69-2 |
|
Pan Bromo Domain Inhibitor |
X |
|
|
|
|
|
| Brompheniramine Maleate |
980-71-2 |
BPN; Bromfed; Bromfenex; Dimetane; Dimetapp; Lodrane |
Antihistamine Agent |
X |
|
|
|
|
|
| Broxyquinoline |
521-74-4 |
Dibromohydroxyquinoline |
Antimicrobial Agent |
X |
|
|
|
|
|
| BSK_4925 |
Not Listed |
Lymphocyte Specific Kinase |
Lck Inhibitor |
X |
|
|
|
|
|
| BSK_anti-CTLA4 |
Not Listed |
|
CTLA4 Inhibitor |
X |
|
|
|
|
|
| Bucladesine |
362-74-3 |
Actosin; Dibutyryl cAMP; Dibutyryl cyclic AMP |
PDE4 Inhibitor |
X |
|
|
|
|
|
| Budesonide |
51333-22-3 |
Budeson; Entocort; Preferid; Pulmicort; Spirocort |
Glucocorticoid Receptor (GR) Agonist |
X |
X |
|
|
X |
|
| Bupropion Hydrochloride |
34841-39-9 |
Amfebutamone; Budeprion; Bupropion; Elontril; Prexaton; Quomem; Voxra; Wellbutrin |
NDRI |
X |
|
|
|
|
|
| Busulfan |
55-98-1 |
Busulfex; Myleran |
Alkylating Antineoplastic Agent |
X |
|
|
|
|
|
| BW 245C |
75693-75-3 |
BW-245C; BW245C |
DP Agonist |
X |
|
|
|
|
|
| BW 246C |
65705-83-1 |
8-epi BW 245C |
DP Agonist |
X |
|
|
|
|
|
| C188-9 |
432001-19-9 |
TTI-101 |
STAT3 Inhibitor |
X |
X |
|
|
|
|
| Cabozantinib |
849217-68-1 |
BMS-907351; Cometriq; XL184 |
VEGFR2 Inhibitor |
X |
X |
X |
X |
|
|
| Caffeine |
58-08-2 |
1,3,7-Trimethylxanthine, Caffeine |
Agonist of Adenosine receptor |
X |
|
|
|
|
New – 2025 |
| Calcipotriene |
112965-21-6 |
Daivonex; Dovonex; Sorilux |
Synthetic Calcitriol Derivative |
X |
|
|
|
|
|
| Calcitriol |
32222-06-3 |
Calcijex; Calcitriolum; Decostriol; Rocaltrol; Silkis; Vectical |
Vitamin D Receptor (VDR) Agonist |
X |
|
|
|
|
|
| Calcium Chloride |
10043-52-4 |
CaCl2; Calcium Chloride Anhydrous |
Salt |
X |
|
|
|
|
|
| Camostat Mesylate |
59721-29-8 |
FOY305; FOY0S980 |
Serine Protease Inhibitor |
X |
X |
|
|
|
|
| Canakinumab |
914613-48-2 |
Ilaris; ACZ885, ACZ-885 |
IL-1β Sink |
X |
|
|
|
|
|
| Cantharidin |
56-25-7 |
Cantharone |
Protein Phosphatase 2A (PP2A) Inhibitor |
X |
|
|
|
|
|
| CAPE |
104594-70-9 |
Caffeic Acid Phenethyl Ester; Phenethyl caffeate |
15-Lipoxygenase Inhibitor |
X |
|
|
|
|
|
| Carbimazole |
22232-54-8 |
Athyromazole |
Antithyroid Agent |
X |
|
|
|
|
|
| Carboplatin |
|
Paraplat; Paraplatin; Paraplatin-AQ |
DNA Repair Inhibitor |
|
|
X |
|
|
|
| Carfilzomib |
868540-17-4 |
Kyprolis; PR-171 |
Proteasome Inhibitor |
X |
|
|
|
|
|
| Carmofur |
61422-45-5 |
1-hexylcarbamoyl-5-fluorouracil; HCFU |
Pyrimidine Analogue; Antineoplastic Agent |
X |
|
|
|
|
|
| Carprofen |
53716-49-7 |
Imadyl; Imafen; Novox; Quellin; Rimadyl; Rovera; Vetprofen |
NSAID |
X |
|
|
|
|
|
| Carvedilol |
72956-09-3 |
Beta Blocker; Carvedilolum; Coreg; Coreg CR; SKF 105517 |
Adrenergic Receptor Inhibitor |
X |
|
|
|
|
|
| Caspofungin Acetate |
179463-17-3 |
Cancidas; L-743,872; MK 0991 |
Antimicrobial Agent |
X |
|
|
|
|
|
| CAY10410 |
596104-94-8 |
9,10-dihydro-15-deoxy-Δ12,14-PGJ2 |
PPARγ Agonist |
X |
|
|
|
|
|
| CCG-1423 |
285986-88-1 |
Myocardin-related Transcription Factor-A |
MRTF-A Inhibitor; Rho Kinase/ROCK Signaling Inhibitor |
X |
X |
|
|
|
|
| CDDO Methyl Ester |
218600-53-4 |
Bardoxolone Methyl; NSC 713200; RTA 402; TP-155 |
Nrf2 Activator; Triterpenes |
X |
|
|
|
|
|
| Ceftazidime Pentahydrate |
78439-06-2 |
Fortaz; Tazicef |
Antibiotic Agent |
X |
|
|
|
|
|
| Celecoxib |
169590-42-5 |
Celebrex, Celecoxibum |
COX-2 Inhibitor |
X |
|
|
|
|
New – 2025 |
| Cepharanthine |
481-49-2 |
|
Anti-inflammatory Agent; Antineoplastic Agent |
X |
|
|
|
|
|
| Cerivastatin |
143201-11-0 |
Baycol; Cerivastatin Acid; Lipobay |
HMG-CoA Reductase Inhibitor |
X |
|
|
|
|
|
| Cetirizine Dihydrochloride |
83881-51-0 |
Alerlisin; Reactine; Zyrtec |
Antihistamine Agent; GPCR Ligand |
X |
|
|
|
|
|
| Cetrimonium Bromide |
57-09-0 |
CTAB; Centimide; Cetyltrimethylammonium Bromide; Hexadecyltrimethylammonium Bromide |
Antimicrobial Agent |
X |
|
|
|
|
|
| Cetuximab |
|
Anti-EGFR; Erbitux; IMC-C225 |
EGFR Inhibitor |
X |
|
X |
X |
|
|
| Cetylpyridinium Chloride |
123-03-5 |
|
Antiseptic Agent |
X |
|
|
|
|
|
| CFM 1571 Hydrochloride |
|
|
sGC Activator |
|
X |
|
|
|
|
| CGP 52608 |
87958-67-6 |
|
RORα Ligand |
X |
|
|
|
|
|
| CH223191 |
301326-22-7 |
|
AhR Inhibitor |
X |
|
|
|
|
|
| CHIR-99021 Hydrochloride |
252917-06-9 |
CT99021 |
GSK-3α/β Inhibitor |
X |
|
X |
|
|
|
| Chlorambucil |
305-03-3 |
Ambochlorin; CHLORAMBUCIL; Chloraminophen; Leukeran |
Alkylating Agent |
X |
|
|
|
|
|
| Chlorocresol |
59-50-7 |
4-chloro-3-cresol; 4-chloro-3-methylphenol |
Antiseptic Agent |
X |
|
|
|
|
|
| Chloroquine Phosphate |
50-63-5 |
Aralen; Resoquine; Reumachlor; Sanoquin |
Antimicrobial Agent |
X |
|
|
|
|
|
| Chlorothiazide |
58-94-6 |
Diuril |
Antihypertensive Agent; Diuretic Agent |
X |
|
|
|
|
|
| Chlorprothixene |
113-59-7 |
Chlorprothixenum; Clorprotixeno; Taractan; Truxal |
Antipsychotic Agent |
X |
|
|
|
|
|
| Chlorquinaldol |
72-80-0 |
Sterosan |
Antimicrobial Agent |
X |
|
|
|
|
|
| Cholecalciferol |
67-97-0 |
Calciol; Colecalciferol; Oleovitamin D3; Vitamin D3 |
Vitamin D Receptor (VDR) Agonist |
X |
|
|
|
|
|
| Cilnidipine |
132203-70-4 |
Atelec; Cinalong; Siscard |
Calcium Channel Blocker |
X |
|
|
|
|
|
| Cilostazol |
73963-72-1 |
Cilostazole; Cilostazolum; Pletaal; Pletal |
PDE Inhibitor |
XZ |
|
|
|
|
|
| Cinacalcet Hydrochloride |
364782-34-3 |
AMG-073 HCl |
Calcimimetic Agent; Extracellular Calcium-sensing Receptor Agonist |
X |
|
|
|
|
|
| Cinchophen |
132-60-5 |
Atophan; Phenaquin; Quinophan |
Analgesic Drug |
X |
|
|
|
|
|
| Ciprofloxacin Hydrochloride |
85721-33-1 |
BAY-o 9867; Cetraxal; Ciloxan; Cipro; Ciprol; NSC 620634 |
Antimicrobial Agent |
X |
|
|
|
|
|
| Cisplatin |
15663-27-1 |
CACP; Cisplatina; Cisplatinum; DDP; Neoplatin; Platinol-AQ |
DNA Alkylating Agent |
X |
|
X |
|
|
|
| Cladribine |
4291-63-8 |
2-CdA; 2-Chlorodeoxyadenosine; Leustatin |
Antineoplastic Agent |
X |
|
|
|
|
|
| Clemastine |
17-7-4 |
Clemastina; Clemastinum |
Antihistamine Agent |
X |
|
|
|
|
|
| Clexane |
|
Ardeparin; Enoxaparin; Enoxaparin Sodium; Heparin; Nadroparin; Tinzaparin |
Anticoagulant Agent |
X |
|
|
|
|
|
| CLI-095 |
|
Meclastin; Resatorvid; TAK-242 |
TLR4 Inhibitor |
X |
|
X |
X |
|
|
| Climbazole |
38083-17-9 |
Baypival; Baysan |
Antimicrobial Agent |
X |
|
|
|
|
|
| Clofarabine |
123318-82-1 |
CAFdA; Clofarex; Clolar; Evoltra |
Nucleic Acid Synthesis Inhibitor |
X |
|
|
|
|
|
| Clofazimine |
2030-63-9 |
Lamprene |
Antimycobacterial Agent |
X |
|
|
|
|
|
| Cloprostenol |
|
(+)-16-m-chlorophenoxy Tetranor Prostaglandin F2α |
Prostaglandin F (FP) Receptor Agonist; PGF2α Analog |
X |
|
|
|
|
|
| Closantel Sodium |
61438-64-0 |
|
Antimicrobial Agent |
X |
|
|
|
|
|
| Clozapine |
5786-21-0 |
Clozapinum; Clozaril; Fazaclo; Versacloz |
Antipsychotic Agent |
X |
|
|
|
|
|
| Cobalt(II) Chloride Hexahydrate |
7791-13-1 |
Cobaltous Chloride Hexahydrate |
Inorganic Compound |
X |
|
X |
|
|
|
| Cobicistat |
1004316-88-4 |
GS-9350; GS-9350, Tybost; Tybost |
CYP3A Inhibitor |
|
|
|
|
|
|
| Coffee Extract |
|
|
Coffee Extract |
X |
|
|
|
|
|
| COH34 |
906439-72-3 |
|
PARG inhibitor |
X |
|
|
|
|
New – 2025 |
| Colchicine |
114977-28-5 |
Colchicin; Colchicina; Colchicinum; Colcrys; Mitigare |
Microtubule Disruptor |
X |
|
X |
X |
|
|
| Concanamycin A |
80890-47-7 |
Antibiotic X 4357B; NSC 674620; X 4357B |
V-ATPase Inhibitor |
X |
|
|
|
|
|
| Concanavalin A Type VI |
11028-71-0 |
|
Purified Lectin |
X |
|
|
|
|
|
| Copper(II) Sulfate |
7758-98-7 |
|
Glucose-6-phosphate Dehydrogenase (G6PD) Inhibitor; Paraoxonase Inhibitor |
X |
|
|
|
|
|
| Cortistatin-14 |
186901-48-4 |
Cortistatin14 |
Steroidal Alkaloids |
X |
|
|
|
|
|
| CP 55,940 |
|
|
Cannabinoid (CB) Receptor Agonist |
X |
|
|
|
|
|
| CPG 52364 |
|
|
TLR7/TLR8/TLR9 Inhibitor |
X |
|
|
|
|
|
| Crisaborole |
|
Eucrisa |
PDE4 Inhibitor |
X |
|
|
|
|
|
| Crizotinib |
877399-52-5 |
PF 2341066; PF-02341066; Xalkori |
Anticancer Agent; ALK Tyrosine Kinase Receptor Inhibitor; HGFR Inhibitor |
X |
|
X |
X |
|
|
| Cudetaxestat |
1782070-21-6 |
BLD-0409, PAT-409 |
ATX Inhibitor |
|
X |
|
|
|
New – 2025 |
| Curcumin |
|
|
Natural Phenol |
|
X |
X |
|
X |
|
| Cyanocobalamin |
68-19-9 |
Cyanocob(III)alamin; Nascobal; Vitamin B12 |
Vitamin B12 Analogue |
X |
|
|
|
|
|
| Cycloheximide |
66-81-9 |
Actidione; Cicloheximide; Kaken; Naramycin A |
Protein Synthesis Inhibitor |
X |
|
|
|
|
|
| Cyclopentyl Adenosine |
|
|
Adenosine A1 Receptor Agonist |
X |
|
|
|
|
|
| Cyclosporin A |
59865-13-3 |
CyA; Cyclosporine; Gengraf; Neoral; Restasis; Sandimmune |
Calcineurin Inhibitor; Cyclophilin A Modulator |
X |
|
X |
X |
X |
|
| Cystamine dihydrochloride |
56-17-7 |
|
Transglutaminase inhibitor |
X |
|
|
|
|
New – 2025 |
| Cysteamine hydrochloride |
156-57-0 |
2-Aminoethanethiol hydrochloride |
2-Aminoethanethiol hydrochloride; 2-Mercaptoethylamine hydrochloride |
X |
|
|
|
|
New – 2025 |
| Cytarabine |
147-94-4 |
Ara-C; Arabinosylcytosine; Cytosar; Cytosine Arabinoside |
DNA Synthesis Inhibitor |
X |
|
|
|
|
|
| Dabrafenib |
|
GSK2118436; Tafinlar |
BRAF Inhibitor |
X |
|
X |
X |
|
|
| Dacomitinib |
|
Vizimpro |
EGFR Inhibitor |
X |
|
|
X |
|
|
| Dactolisib |
915019-65-7 |
BEZ235; NVP-BEZ235 |
PI3K Inhibitor; mTOR Inhibitor |
X |
|
X |
X |
|
|
| Dalcetrapib |
211513-37-0 |
JTT-705 |
Cholesterylester Transfer Protein (CETP) Inhibitor |
X |
|
|
|
|
|
| Danofloxacin Mesylate |
119478-55-6 |
Advoci; CP-76136-27; Nofloxacin |
Antimicrobial Agent |
X |
|
|
|
|
|
| Danusertib |
827318-97-8 |
PHA-739358 |
Aurora Kinase Inhibitor |
X |
|
|
|
|
|
| Daprodustat |
960539-70-2 |
GSK1278863 |
Hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor |
X |
|
|
|
|
New – 2025 |
| Daratumumab |
945721-28-8 |
Anti-Human CD38, Human Antibody |
Anti-CD38 Antibody |
X |
|
|
|
|
|
| Darifenacin Hydrogen Bromide |
133099-07-7 |
Enablex; UK 88525-04 |
Muscarinic Acetylcholine Receptor Inhibitor |
X |
|
|
|
|
|
| Darunavir Ethanolate |
635728-49-3 |
Prezista; TMC114 |
Protease Inhibitor |
X |
|
|
|
|
|
| Dasatinib |
302962-49-8 |
BMS-354825; Sprycel |
Multikinase Inhibitor (Src tyr Kinase, BCR/Abl) |
X |
X |
X |
X |
|
|
| Daunorubicin Hydrochloride |
23541-50-6 |
Acetyladriamycin; Daunomycin; Daunorubicina; Daunorubicine ; Daunorubicinum; Leukaemomycin C; Rubidomycin |
DNA Topoisomerase Inhibitor |
X |
|
X |
|
|
|
| dBET1 |
1799711-21-9 |
|
BRD4 PROTAC |
X |
|
|
|
|
|
| Decitabine |
2353-33-5 |
Azadc; Dacogen; Dezocitidine |
Nucleic Acid Synthesis Inhibitor |
X |
|
|
|
|
|
| Defactinib |
1073154-85-4 |
VS-6063; PF-04554878 |
FAK inhibitor
|
X |
|
|
|
|
New – 2025 |
| Defactinib |
1073154-85-4 |
VS-6063; PF-04554878 |
FAK inhibitor |
|
|
|
|
X |
New – 2025 |
| Deferasirox |
201530-41-8 |
Exjade; ICL670A |
Iron Chelating Agent |
X |
|
|
|
|
|
| Deferoxamine Mesylate |
70-51-9 |
DFOA; DFOM; Deferoxamina; Deferoxamine; Deferoxaminum; Deferrioxamine |
Iron Chelating Agent |
X |
|
|
|
|
|
| Denosumab |
|
Prolia; Xgeva |
RANKL Inhibitor |
X |
|
X |
|
|
|
| Deoxyarbutin |
53936-56-4 |
|
Tyrosinase Inhibitor |
X |
|
|
|
|
|
| Dequalinium Chloride |
522-51-0 |
Danical; Decabis; Dequafungan |
Antimicrobial Agent; PKC Inhibitor |
X |
|
|
|
|
|
| Deruxtecan |
1599440-13-7 |
MC-GGFG-DXD |
ADC Payload |
X |
|
|
|
|
|
| Desloratadine |
100643-71-8 |
Aerius; Clarinex; Descarboethoxyloratadine |
Antihistamine Agent |
X |
|
|
|
|
|
| Desonide |
638-94-8 |
Desowen; Tridesilon |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Deucravacitinib |
1609392-27-9 |
BMS-986165 |
Tyk2 Inhibitor |
X |
|
|
|
X |
|
| Dexamethasone |
50-02-2 |
Baycadron; Decadron; Dexametasona; Maxidex; Ozurdex |
Glucocorticoid Receptor (GR) Agonist |
X |
|
X |
|
X |
|
| Dexlansoprazole |
138530-94-6 |
Dexilant; Kapidex |
Proton Pump Inhibitor |
X |
|
|
|
|
|
| Dexmedetomidine |
113775-47-6 |
Dex; Precedex |
α2 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Dextromethorphan |
125-71-3 |
DXM, D-Methorphan |
Noncompetitive NMDA receptor antagonist |
X |
|
|
|
|
New – 2025 |
| Dibucaine |
85-79-0 |
Cinchocaine; Dermacaine; Nupercainal; Nupercaine |
Anesthetic |
X |
|
|
|
|
|
| Diclofenac Diethylamine |
78213-16-8 |
AK163134; UNII-6TGQ35Z71K |
NSAID |
X |
|
|
|
|
|
| Diclofenac Potassium |
15307-81-0 |
Cambia; Cataflam; UNII-L4D5UA6CB4; Zipsor |
NSAID |
X |
|
|
|
|
|
| Dienogest |
65928-58-7 |
Progestin; Visanne |
Semisynthetic Steroidal Progestogen |
X |
|
|
|
|
|
| Diethylstilbestrol |
56-53-1 |
|
11β-hydroxysteroid dehydrogenase 2 inhibitor |
X |
|
|
|
|
New – 2025 |
| Difluprednate |
23674-86-4 |
Durezol |
Corticosteroid |
X |
|
|
|
|
|
| Digoxigenin |
1672-46-4 |
Digitoxigenin; Uzarigenin |
Hapten |
X |
|
|
|
|
|
| Dihydrotestosterone |
521-18-6 |
Anaboleen; Androlone; Androstanolone; Stanaprol; Stanolone |
AR Agonist |
X |
|
|
|
|
|
| Dimethyl Fumarate |
624-49-7 |
BG-12; DMF; Tecifidera |
NFκB Inhibitor; Nrf2 Activator |
X |
|
|
|
|
|
| Diminazene Aceturate |
908-54-3 |
Diminazeno; Diminazenum |
ACE Activator |
X |
|
|
|
|
|
| Diphenylpyraline Hydrochloride |
132-18-3 |
Allerzine; Diaphen; Histalert |
Antihistamine Agent; GPCR Ligand |
X |
|
|
|
|
|
| Diprophylline |
479-18-5 |
Dilor |
PDE Inhibitor; Adenosine Receptor Antagonist |
X |
|
|
|
|
|
| Dipyridamole |
58-32-2 |
Cardoxin; Cleridium 150; Curantyl; Permole; Persantin; Persantine |
PDE Inhibitor |
X |
|
X |
|
|
|
| Disulfiram |
97-77-8 |
Antabuse; Tetraethylthiuram Disulfide |
Aldehyde Dehydrogenase Inhibitor |
X |
|
|
|
|
|
| Donepezil Hydrochloride |
120011-70-3 |
Aricept; Donepezilum |
Cholinesterase Inhibitor |
X |
|
|
|
|
|
| Doramapimod |
285983-48-4 |
BIRB-796; BIRB796 |
p38 MAPK Inhibitor |
X |
X |
|
|
|
|
| Dorzolamide Hydrochloride |
120279-96-1 |
MK-507 |
Carbonic Anhydrase Inhibitor |
X |
|
|
|
|
|
| Doxazosin Mesylate |
74191-85-8 |
Cardura |
α1 Adrenergic Receptor Inhibitor |
X |
|
|
|
|
|
| Doxorubicin Hydrochloride |
25316-40-9 |
Adriamycin; Doxorubicine; Doxorubicinum; Hydroxydaunorubicin |
DNA Topoisomerase Inhibitor |
X |
|
|
|
|
|
| D-Pantethine |
16816-67-4 |
Pantethine; Pantetina; Pantomin; Pantosin |
Cofactor Precursor |
X |
|
|
|
|
|
| Droperidol |
548-73-2 |
Dehydrobenzperidol; Dridol; Droleptan; Inapsine |
Dopamine Receptor (D2) Inhibitor; 5-HT2A Receptor Inhibitor |
X |
|
|
|
|
|
| Drospirenone |
67392-87-4 |
1,2-dihydrospirorenone; Yasmin |
Progesterone Receptor (PR) Agonist |
X |
|
|
|
|
|
| Dupilumab |
1190264-60-8 |
REGN-668 |
Anti-IL-4 Antibody |
X |
|
|
|
X |
|
| Durvalumab |
|
Imfinzi |
Anti-PD-L1 Antibody |
|
|
X |
X |
|
|
| Dydrogesterone |
152-62-5 |
Duphaston; Isopregnenone |
Progesterone Receptor (PR) Agonist |
X |
|
|
|
|
|
| Edaravone |
89-25-8 |
MCI-186; Radicut |
Antioxidant |
X |
|
|
|
|
|
| Eflornithine |
70052-12-9 |
DFMO; MDL71782; RMI71782; α-difluoromethylornithine |
Ornithine Decarboxylase Inhibitor |
X |
|
|
|
|
|
| EGF |
62253-63-8 |
Epidermal Growth Factor |
EGFR Activator |
X |
|
|
|
|
|
| EGFR/ErbB-2/ErbB-4 Inhibitor |
881001-19-0 |
|
EGFR Inhibitor; HER2, HER4 Inhibitor |
X |
|
|
|
|
|
| Eicosapentaenoic Acid |
10417-94-4 |
EPA; Icosapentaenoic Acid |
Omega-3 Fatty Acid; Eicosanoid Precursor |
X |
|
|
|
|
|
| Elafibranor |
923978-27-2 |
GFT505 |
PPARα/δ agonist |
X |
X |
|
|
|
|
| Elesclomol |
488832-69-5 |
STA-4783 |
ROS Inducer |
X |
|
|
|
|
|
| Ellagic Acid |
476-66-4 |
|
Antioxidant Agent |
X |
|
|
|
|
|
| Embelin |
|
|
X-linked Inhibitor of Apoptosis Protein (XIAP) Inhibitor |
|
|
X |
|
|
|
| Emricasan |
254750-02-2 |
|
Caspase Inhibitor |
X |
|
|
|
|
|
| Enbrel |
185243-69-0 |
Etanercept; TNF-R2 |
TNFα Inhibitor |
X |
|
|
|
|
|
| ENMD-2076 |
934353-76-1 |
|
Kinase Inhibitor |
X |
|
|
|
|
|
| Entinostat |
209783-80-2 |
MS-275; SNDX-275 |
HDAC Inhibitor |
X |
|
|
|
|
|
| Entrectinib |
1108743-60-7 |
NMS-E628 |
TrkA/B/C/ROS1/ALK Inhibitor |
X |
|
X |
X |
|
|
| Epacadostat |
|
INCB024360 |
IDO Inhibitor |
X |
|
X |
X |
|
|
| Epalrestat |
82159-09-9 |
ONO-2235 |
Aldose Reductase Inhibitor |
X |
X |
|
|
|
|
| Epothilone B |
152044-54-7 |
EPO 906; EPO906; Patupilone |
Microtubule Disruptor |
X |
|
|
|
|
|
| Epothilone D |
189453-10-9 |
Desoxyepothilone B |
Microtubule Disruptor |
X |
|
X |
X |
|
|
| Eprazinone Dihydrochloride |
10402-53-6 |
746CE; Eftapan; Mucitux; NSC 317935; Resplen; Rozuplen |
Mucolytic Agent |
X |
|
|
|
|
|
| Eribulin Mesylate |
441045-17-6 |
E7389 |
Microtubule Binder |
X |
|
X |
|
X |
|
| ERK5-IN-1 |
1234479-76-5 |
|
ERK5 Inhibitor |
X |
|
|
|
|
|
| Erlotinib |
183321-74-6 |
CP-358,774; Erlotinib Hydrochloride; OSI-774; Tarceva |
EGFR Inhibitor |
X |
X |
X |
X |
|
|
| Erythromycin |
114-07-8 |
Abomacetin; Eritromicina; Ilotycin |
Antibiotic Agent |
X |
|
|
|
|
|
| Ethacridine Lactate |
6402-23-9 |
Acrinol; Rivanol |
DNA Intercalating Antiseptic Agent |
X |
|
|
|
|
|
| Ethacrynic Acid |
58-54-8 |
Edecrin |
Diuretic Agent |
X |
|
|
|
|
|
| Ethanol |
64-17-5 |
Alcohol; Ethyl Alcohol; Ethyl Hydroxide |
GABA-A Receptor Agonist; NMDA Receptor Inhibitor |
X |
|
|
|
|
|
| Ethionamide |
536-33-4 |
|
Antimicrobial Agent |
X |
|
|
|
|
|
| Ethosuximide |
77-67-8 |
Aethosuximide; Atysmal; Ethosuximidum; Etosuximida |
Voltage-gated T-type Calcium Channel Blocker |
X |
|
|
|
|
|
| Ethoxzolamide |
452-35-7 |
Ethoxyzolamide |
Carbonic Anhydrase Inhibitor |
X |
|
|
|
|
|
| Ethyl Pyruvate |
617-35-6 |
Ethyl 2-Oxopropanoate; Pyruvic Acid Ethyl Ester |
Anti-inflammatory Agent |
X |
|
|
|
|
|
| Ethylenediamine |
107-15-3 |
|
Organic Compound |
X |
|
|
|
|
|
| Etodolac |
41340-25-4 |
Etodolaco; Etodolacum; Etodolic acid; Lodine |
COX-2 Inhibitor |
X |
|
|
|
|
|
| Etomidate |
33125-97-2 |
Amidate |
Anaesthetic Agent; GABA-A Agonist |
X |
|
|
|
|
|
| Etoposide |
33419-42-0 |
VP-16 |
DNA Topoisomerase (TOPO) II Inhibitor |
X |
|
|
|
|
|
| Etrasimod |
1206123-37-6 |
APD334 |
S1P receptor modulator |
X |
|
|
|
|
New – 2025 |
| Etravirine |
269055-15-4 |
Intelence; TMC-125; TMC125 |
NNRTI |
X |
|
|
|
|
|
| Everolimus |
159351-69-6 |
Afinitor; Certican; Evertor; RAD001; Zortress |
mTOR Inhibitor |
X |
X |
X |
|
X |
|
| Exemestane |
107868-30-4 |
Aromasin |
Steroidal Aromatase Inhibitor |
X |
|
|
|
|
|
| Ezetimibe |
163222-33-1 |
Ezedoc; SCH-58235; Zetia |
Antilipemic Agent |
X |
|
|
|
|
|
| Famprofazone |
22881-35-2 |
Gewodin; Gewolen |
NSAID |
X |
|
|
|
|
|
| Fasudil |
103745-39-7 |
Fasudil Hydrochloride; HA-1077 |
ROCK1, ROCK2 Inhibitor |
X |
X |
|
|
|
|
| FCCP |
370-86-5 |
Carbonyl cyanide p-trifluoromethoxyphenylhydrazone |
Uncoupling Agent; Ionophore |
X |
|
|
|
|
|
| Febuxostat |
144060-53-7 |
Adenuric; Feburic; Goturic; Uloric |
Xanthine Oxidase Inhibitor |
X |
|
|
|
|
|
| Fedratinib |
936091-26-8 |
Inrebic; SAR302503; TG101348 |
JAK2 Inhibitor |
X |
|
X |
|
|
|
| Fenbendazole |
43210-67-9 |
Panacur |
Anthelmintic Agent; Microtubule Disruptor |
X |
|
|
|
|
|
| Fenoprofen Calcium Dihydrate |
34597-40-5 |
Fenopron; Nalgesic; Progesic |
COX Inhibitor |
X |
|
|
|
|
|
| Fenspiride Hydrochloride |
|
NAT-333; NDR-5998A |
PDE Inhibitor |
X |
|
|
|
|
|
| Fexofenadine Hydrochloride |
153439-40-8 |
Allegra |
H1 Receptor Inhibitor |
X |
|
|
|
|
|
| Fezolinetant |
1629229-37-3 |
ESN-364 |
neurokinin 3 receptor antagonist |
X |
|
|
|
|
New – 2025 |
| FICZ |
172922-91-7 |
|
AhR Agonist |
X |
|
X |
|
|
|
| Fidaxomicin |
873857-62-6 |
Dificid; Dificlir; OPT-80; PAR-101 |
Antibiotic Agent |
X |
|
|
|
|
|
| Filgotinib |
|
GLPG0634 |
JAK1 Inhibitor |
X |
X |
X |
|
|
|
| Finasteride |
98319-26-7 |
Propecia; Proscar |
Type II, Type III 5α-reductase Inhibitor |
X |
|
|
|
|
|
| Fingolimod |
162359-56-0 |
FTY720; Gilenya |
S1P Receptor Agonist |
X |
|
|
|
|
|
| Flagellin |
|
|
TLR5 Agonist |
X |
|
|
|
|
|
| Fleroxacin |
79660-72-3 |
FLRX; Megalone ; Megalosin; Quinodis |
Antimicrobial Agent |
X |
|
|
|
|
|
| Flubendazole |
31430-15-6 |
Flutelmium |
Antimicrobial Agent |
X |
|
|
|
|
|
| Fludarabine |
21679-14-1 |
2-Fluoro-Ara-A; F-ara-A; Fludara; NSC 118218; Oforta |
STAT1 Inhibitor; DNA Synthesis Inhibitor |
X |
|
|
|
|
|
| Fludrocortisone |
127-31-1 |
Fludrocortisona; Fludrocortisonum; Fluohydrocortisone |
Glucocorticoid Receptor (GR) Agonist; Mineralocorticoid Receptor (MR Agonist) |
X |
|
|
|
|
|
| Flumazenil |
78755-81-4 |
Anexate; Flumazepil; Lanexat |
GABA/Benzodiazepine Receptor Inhibitor |
X |
|
|
|
|
|
| Flumethasone |
2002-29-1 |
Locacorten; Locorten; Orsalin; U-10974 |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Flunarizine Dihydrochloride |
30484-77-6 |
Flunarizina |
Calcium Channel Blocker; Antihistamine Agent |
X |
|
|
|
|
|
| Fluorometholone Acetate |
|
Eflone; Flarex; Fluorometholone 17-acetate; Oxylone Acetate |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Fluorouracil |
51-21-8 |
5-FU; 5-FU; 5-Fluracil; Adrucil; Fluoro Uracil; Fluoroplex; Fluouracil |
Thymidylate Synthase (TS) Inhibitor; Pyrimidine Analog |
X |
|
X |
|
|
|
| Fluoxetine |
54910-89-3 |
Adofen; LY-110140; Prozac; Sarafem; Symbyax |
Antidepressant; SSRI Inhibitor |
X |
|
|
|
|
|
| Flurbiprofen |
5104-49-4 |
Ansaid; FLP; Ocufen |
COX Inhibitor; NSAID |
X |
|
|
|
|
|
| Fluticasone Propionate |
80474-14-2 |
Fluticason; Fluticasona; Fluticasone; Fluticasonum |
Glucocorticoid Receptor (GR) Agonist; Progesterone Receptor (PR) Agonist |
X |
X |
|
|
|
|
| Fluvastatin |
93957-54-1 |
Fluvastatin Sodium; Lescol |
HMG-CoA Reductase Inhibitor |
X |
|
|
|
|
|
| Fluvoxamine Maleate |
61718-82-9 |
Luvox |
SSRI |
X |
|
|
|
|
|
| FM-381 |
|
DRX_FM-381 |
JAK3 Inhibitor |
X |
|
|
|
|
|
| fMLP |
59880-97-6 |
FMLP; N-Formylmethionyl-leucyl-phenylalanine |
FPR Agonist |
X |
|
|
|
|
|
| Forskolin |
66575-29-9 |
Coleonol; Colforsin; Colforsina; Colforsine |
Adenylyl Cyclase Activator |
X |
|
|
|
|
|
| Fosaprepitant Dimeglumine |
265121-04-8 |
Ivemend; L 758298; UNII-6L8OF9XRDC |
Neurokinin-1 Receptor Inhibitor |
X |
|
|
|
|
|
| Fosbretabulin Disodium |
168555-66-6 |
CA4DP; Zybrestat |
Microtubule Disruptor |
X |
|
|
|
|
|
| Foscenvivint |
1422253-38-0 |
PRI-724 |
CBP/β-Catenin Inhibitor |
X |
|
|
|
|
|
| Fostamatinib |
1025687-58-4 |
R406 |
Syk Inhibitor |
X |
|
|
|
|
|
| FR180204 |
865362-74-9 |
|
ERK Inhibitor |
X |
|
|
|
|
|
| FSL-1 |
|
|
TLR2/TLR6 Agonist |
X |
|
|
|
|
|
| Ftorafur |
17902-23-7 |
Tefudex; Tegafur-uracil; UFT; Uftotral; Ufur |
Chemotherapeutic Agent |
X |
|
|
|
|
|
| Fucoidan |
9072-19-9 |
|
Caspase-3 Activator |
X |
|
|
|
|
|
| Fulvestrant |
129453-61-8 |
Faslodex |
Estrogen Receptor (ER) Inhibitor |
X |
|
|
|
|
|
| Fumagillin |
23110-15-8 |
Fumidil |
Angiogenesis Inhibitor; MetAP2 Inhibitor |
X |
|
|
|
|
|
| Galeterone |
851983-85-2 |
TOK-001 |
CYP17A1 Inhibitor |
X |
|
|
|
|
|
| Galunisertib |
700874-72-2 |
LY2157299 |
TGFβR1 Kinase Inhibitor |
X |
X |
X |
X |
|
|
| Gandotinib |
1229236-86-5 |
LY2784544 |
JAK2 Inhibitor |
X |
|
X |
|
|
|
| GB1107 |
1978336-61-6 |
|
Inhibitor of Galectin-3 |
X |
|
|
|
|
New – 2025 |
| GDC0834 |
|
1133432-49-1 |
BTK Inhibitor |
X |
|
X |
X |
|
|
| GDC0853 |
|
RG-7845 |
BTK Inhibitor |
X |
|
|
|
|
|
| GDC0879 |
|
|
B-Raf/C-Raf Inhibitor |
|
|
X |
|
|
|
| GDC0941 |
957054-30-7 |
GDC-0941; Pictilisib |
PI3Kα/δ Inhibitor |
X |
X |
X |
|
X |
|
| Gefitinib |
184475-35-2 |
Iressa; ZD 1839 |
EGFR Inhibitor |
X |
|
X |
|
|
|
| Geldanamycin |
30562-34-6 |
Geldanomycin |
Hsp90 Inhibitor |
X |
|
X |
|
|
|
| Gemcitabine Hydrochloride |
122111-03-9 |
Gemzar; LY-188011; dFdC; dFdCyd |
Nucleoside Metabolic Inhibitor |
X |
|
X |
X |
|
|
| Gemfibrozil |
25812-30-0 |
Gemfibrozilo; Gemfibrozilum; Lopid |
PPARα Agonist |
X |
|
|
|
|
|
| Genistein |
446-72-0 |
Genisteol; Genisterin; NSC-36586 |
Phytoestrogen |
X |
|
|
|
|
|
| Gestodene |
60282-87-3 |
15-dehydronorgestrel |
Progesterone Receptor (PR) Agonist |
X |
|
|
|
|
|
| GF109203X |
133052-90-1 |
Bisindolylmaleimide I |
PKC (c+n) Inhibitor |
X |
|
|
|
|
|
| Gilteritinib |
1254053-43-4 |
Xospata |
Tyrosine Kinase Inhibitor |
X |
|
|
|
|
|
| GKT137831 |
1218942-37-0 |
GKT-137831 |
NOX1/NOX4 Inhibitor |
X |
X |
|
|
|
|
| Glasdegib |
1095173-27-5 |
PF-04449913 |
Smoothened (SMO) Inhibitor |
X |
|
|
|
|
|
| Glatimer Acetate |
|
Copaxone |
Immunomodulating Agent |
X |
|
|
|
|
|
| Glesatinib |
|
|
Tyrosine Kinase Inhibitor |
X |
|
|
|
|
|
| Gliquidone |
33342-05-1 |
Beglynor; Glikvidon; Gliquidonum; Glurenorm |
KATP Channel Blocker |
X |
|
|
|
|
|
| GLP-1 |
|
Proglucagon (72-108) |
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist |
X |
|
|
|
|
|
| GLPG1205 |
1445847-37-9 |
|
GPR84 Antagonist |
X |
X |
|
|
|
|
| GLPG3970 |
2403733-82-2 |
Compound 88 |
SIK2/3 Inhibitor |
X |
|
|
|
|
|
| GLPG4399 |
|
|
SIK3 Inhibitor |
X |
|
|
|
|
|
| Glyburide |
|
|
Sulfonylurea; Antihyperglycemic Agent |
X |
|
|
|
|
|
| GM-CSF |
83869-56-1 |
CSF2; Leukine; Sargramostim |
Cytokine; Immune Modulator |
X |
|
|
|
|
|
| Go 6983 |
133053-19-7 |
|
PKC (c+n) Inhibitor |
X |
|
|
|
|
|
| Golimumab |
|
Simponi |
TNFα Inhibitor |
X |
|
|
|
|
|
| GRP |
|
Gastrin-releasing Peptide |
Stimulates Gastrin Release; Neuropeptide |
X |
|
|
|
|
|
| GS-441524 |
1191237-69-0 |
|
Metabolite of Remdesivir |
X |
|
|
|
|
|
| GSK Compound 18 |
1221277-91-3 |
LPM029_300303_01 |
LXR Agonist |
X |
|
|
|
|
|
| GSK2795039 |
1415925-18-6 |
|
NOX2 Inhibitor |
X |
|
|
|
|
|
| GSK2801 |
|
GSK 2801; KB-146016 |
BAZ2 Bromodomain Inhibitor |
X |
|
|
|
|
|
| GSK3326595 |
1616392-22-3 |
EPZ015938 |
PRMT5 Inhibitor |
X |
|
|
|
|
|
| GSK343 |
1346704-33-3 |
|
EZH2 inhibitor |
X |
|
|
|
|
New – 2025 |
| GSK461364A |
929095-18-1 |
GSK 461364A |
PLK1 Inhibitor |
X |
|
X |
|
|
|
| GSK690693 |
937174-76-0 |
GSK 690693 |
AKT Inhibitor |
X |
|
|
|
|
|
| GSKJ4 |
1373423-53-0 |
GSK J4; GTPL8979 |
Histone Demethylase Inhibitor |
X |
|
X |
|
|
|
| GW2580 |
870483-87-7 |
|
cFMS Kinase Inhibitor |
X |
|
|
|
|
|
| GW3965 |
405911-09-3 |
|
LXRα Agonist |
X |
|
|
|
|
|
| GW501516 |
317318-70-0 |
GW-501516 |
PPARδ Agonist |
X |
|
X |
X |
|
|
| H-1152 |
451462-58-1 |
H1152 |
ROCK2 Inhibitor |
X |
X |
|
|
|
|
| H-151 |
941987-60-6 |
|
Antagonist of STING |
X |
|
|
|
X |
New – 2025 |
| H-89 |
127243-85-0 |
5-Isoquinolinesulfonamide; Protein Kinase Inhibitor H-89 |
PKA Inhibitor |
X |
|
|
|
|
|
| Halobetasol Propionate |
66852-54-8 |
Ulobetasol |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| hCG |
|
Human Chorionic Gonadotropin |
Luteinizing Hormone; Choriogonadotropin Receptor Agonist |
X |
|
|
|
|
|
| Hemicholinium Bromide |
312-45-8 |
Hemicholine |
Choline Transporter (ChT) Inhibitor |
X |
|
|
|
|
|
| Hesperadin |
422513-13-1 |
|
Aurora Kinase Inhibitor |
X |
|
|
|
|
|
| HG-9-91-01 |
1456858-58-4 |
Sik Inhibitor 1 |
SIK1/2/3 Inhibitor |
X |
|
|
|
|
|
| HGF |
|
Hepatocyte Growth Factor |
c-Met Inhibitor |
X |
|
|
|
|
|
| Histamine |
51-45-6 |
|
Histamine Receptor Agonist |
X |
|
|
|
|
|
| Histamine Phosphate |
51-74-1 |
|
Histamine Receptor Agonist |
X |
|
|
|
|
|
| HKLM |
|
Heat Killed Listeria monocytogenes |
TLR2 Agonist |
X |
|
X |
|
|
|
| Homatropine Bromide |
51-56-9 |
|
Muscarinic Acetylcholine Receptor (mAChR) Inhibitor |
X |
|
|
|
|
|
| Human anti-CD73 IgG1 |
|
MEDI9447 |
Anti-CD73 Monoclonal Antibody |
|
|
X |
|
|
|
| Human IgG1 |
|
|
IgG1 Control Antibody |
|
|
X |
|
|
|
| Human IgG1 Kappa |
|
|
Immunoglobulin |
X |
|
|
|
|
|
| Human IgG1 mAb R347 Isotype Control |
|
|
IgG1 Control Antibody |
|
|
X |
|
|
|
| Human γ-Globulin |
|
|
Serum Fraction |
X |
|
|
|
|
|
| Hydrochlorothiazide |
58-93-5 |
|
Diuretic Agent |
X |
|
|
|
|
|
| Hydrocortisone |
50-23-7 |
17-Hydroxycorticosterone |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Hydroxychloroquine Sulfate |
747-36-4 |
Ercoquin; Oxychlorochin; Oxychloroquine; Plaquenil; Toremonil |
Antimicrobial Agent |
X |
|
|
|
|
|
| Hydroxyfasudil |
155558-32-0 |
HA 1100 |
ROCK1, ROCK2 Inhibitor |
X |
|
|
|
|
|
| Hydroxyurea |
127-07-1 |
Droxia; Hydrea; Hydroxycarbamide; Litalir |
Antineoplastic Agent; Ribonucleotide Reductase Inhibitor |
X |
|
|
|
|
|
| Hydroxyzine Dihydrochloride |
68-88-2 |
Arcanax; Neurolax |
Antihistamine Agent |
X |
|
|
|
|
|
| Hygromycin B |
31282-04-9 |
|
Antibiotic Agent |
X |
|
|
|
|
|
| Iberdomide |
1323403-33-3 |
CC-220 |
Cereblon (CRBN) E3 ligase modulator |
X |
|
|
|
|
New – 2025 |
| I-BET |
1260907-17-2 |
|
BET Inhibitor |
X |
|
X |
|
|
|
| I-BET-151 |
1300031-49-5 |
GDK1210151A |
BET Inhibitor |
X |
X |
X |
X |
X |
|
| Ibrutinib |
936563-96-1 |
Imbruvica; PCI-32765 |
BTK Inhibitor |
X |
|
X |
X |
X |
|
| Ibudilast |
50847-11-5 |
AV-411; Eyevinal; Ibudilastum; Ketas |
PDE4 Inhibitor |
X |
|
|
|
|
|
| Ibuprofen |
15687-27-1 |
NeoProfen |
COX Inhibitor |
X |
|
|
|
X |
|
| IC-87114 |
371242-69-2 |
IC87114 |
PI3Kδ Inhibitor |
X |
|
X |
|
|
|
| ICI 63197 |
27277-00-5 |
|
PDE4 Inhibitor |
X |
|
|
|
|
|
| Idebenone |
58186-27-9 |
Catena; Raxone; Sovrima |
Synthetic Coenzyme Q10 (CoQ10) Analog |
X |
|
|
|
|
|
| Idelalisib |
870281-82-6 |
CAL-101; GS-1101; Zydelig |
PI3Kδ Inhibitor |
X |
|
X |
X |
X |
|
| IDO-IN-2 |
914471-09-3 |
|
IDO Inhibitor |
X |
|
X |
X |
|
|
| IFNα 2a |
|
IFN-α 2a; INF-α 2a; Interferon α 2a |
Cytokine |
X |
|
|
|
|
|
| IFNα 2b |
|
IFN-α 2b; INF-α 2b; Interferon α 2b |
Cytokine |
X |
|
|
|
|
|
| IFNβ-1b |
145155-23-3 |
Betaseron; INF-β 1b; INFβ 1b; Interferonβ-1b; Interferonβ1b |
Cytokine |
X |
|
|
|
|
|
| IFNγ |
82115-62-6 |
Actimmune; Interferon gamma-1b |
Cytokine |
X |
|
X |
|
|
|
| IgG4 Isotype |
|
|
IgG4 Control Antibody |
X |
|
X |
|
|
|
| IKK 16 |
1186195-62-9 |
IKK Inhibitor VII; IKK-16 |
IKK2 Inhibitor |
X |
|
|
|
|
|
| IKK-2 Inhibitor IV |
507475-17-4 |
|
IKK2 Inhibitor |
X |
|
|
|
|
|
| IL-10 |
130068-27-8 |
Interleukin 10 |
Cytokine |
X |
|
X |
|
|
|
| IL-12 |
632331-09-0 |
Interleukin 12 |
Cytokine |
X |
|
|
|
|
|
| IL-13 |
148157-34-0 |
Interleukin 13 |
Cytokine |
X |
|
|
|
|
|
| IL-17A |
|
Interleukin 17A |
Cytokine |
X |
|
|
|
X |
|
| IL-17F |
|
Interleukin 17F |
Cytokine |
X |
|
|
|
|
|
| IL-1R Antagonist |
566914-00-9 |
Interleukin 1 Receptor Antagonist |
IL-1 Receptor Inhibitor |
X |
|
|
|
|
|
| IL-1β |
97599-21-8 |
Interleukin-1β |
Cytokine |
X |
|
|
|
|
|
| IL-2 |
|
Aldesleukin; Interleukin 2; Proleukin |
Cytokine |
X |
|
|
X |
|
|
| IL-27 |
|
Interleukin 27 |
Cytokine |
X |
|
|
|
|
|
| IL-29 |
|
Interferon λ1; Interleukin 29 |
Cytokine |
X |
|
|
|
|
|
| IL-32 |
|
Interleukin 32 |
Cytokine |
X |
|
|
|
|
|
| IL-33 |
|
Interleukin 33 |
Cytokine |
X |
|
|
|
|
|
| IL-35 |
|
Interleukin 35 |
Cytokine |
X |
|
|
|
|
|
| IL-4 |
207137-56-2 |
Interleukin 4 |
Cytokine |
X |
|
|
|
|
|
| IL-6 Rα |
|
CD126 ; Cluster of Differentiation 126 |
Immunomodulating Agent |
X |
|
|
|
|
|
| IL-8 |
|
CXCL8; Interleukin 8 |
CXCR1/2 Agonist |
X |
|
|
|
|
|
| Iloperidone |
133454-47-4 |
Fanapt |
Antipsychotic Agent |
X |
|
|
|
|
|
| Iloprost |
78919-13-8 |
Ventavis |
EP1 Agonist; Prostanoid IP Receptor Agonist |
X |
|
|
|
|
|
| Imatinib |
152459-95-5 |
Gleevec; Imatinib Methansulfonate; Imatinibum |
BCR-ABL Inhibitor |
X |
X |
|
|
|
|
| Indomethacin |
53-86-1 |
Aconip; Indocin; Indometacina; Indometacine; Indometacinum |
COX Inhibitor |
X |
|
|
|
|
|
| Infliximab |
170277-31-3 |
Remicade |
TNFα Inhibitor |
X |
X |
|
|
X |
|
| Iniparib |
160003-66-7 |
BSI 201 |
PARP Inhibitor |
X |
|
|
X |
|
|
| Insulin Aspart |
|
Novolog |
Insulin Receptor Agonist |
X |
|
|
|
|
|
| Insulin Glargine |
|
Lantus |
Insulin Receptor Agonist |
X |
|
|
|
|
|
| Insulin Lispro |
|
Humalog; Insulin Lispro Recombinant |
Insulin Receptor Agonist |
X |
|
|
|
|
|
| IOX1 |
5852-78-8 |
|
Histone Demethylase JMJD Inhibitor |
X |
|
|
|
|
|
| Ipatasertib |
1001264-89-6 |
GDC-0068, RG7440 |
ATP-competitive pan-Akt inhibitor |
X |
|
|
|
|
New – 2025 |
| Ipilimumab |
477202-00-9 |
MDX-010; MDX-101; MDX-CTLA-4; MOAB-CTLA-4; Yervoy |
CTLA-4 Inhibitor |
X |
|
X |
X |
|
|
| IRAK-1/4 Inhibitor I |
509093-47-4 |
|
IRAK-1/4 Inhibitor |
X |
|
|
|
|
|
| Irinotecan |
100286-90-6 |
CPT-11; Campto; Camptosar; Camptothecin-11 |
DNA Topoisomerase (TOPO) I Inhibitor |
X |
|
X |
|
|
|
| Irsogladine |
57381-26-7 |
|
PDE4 Inhibitor |
X |
|
|
|
|
|
| Isoetharine Mesylate |
530-08-5 |
Isoetarine Mesilate |
β2 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Isoniazid |
54-85-3 |
Isonicotinic acid hydrazide; Isonicotinsaeurehydrazid; Isonicotinylhydrazine |
Antibiotic Agent |
X |
|
|
|
|
|
| Isotretinoin |
4759-48-2 |
13-cis-retinoic acid; Accutane |
RAR/RXR Agonist |
X |
|
|
|
|
|
| Istradefylline |
155270-99-8 |
KW-6002 |
Adenosine A2A Receptor Antagonist |
X |
|
|
|
|
|
| Itraconazole |
84625-61-6 |
Sporanox |
Cytochrome P450 51 Inhibitor, Ergosterol Synthesis InhibitorX |
X |
X |
|
|
|
|
| Ivacaftor |
873054-44-5 |
Kalydeco; VX770 |
CFTR Potentiator |
X |
X |
|
|
|
|
| Ivermectin |
70288-86-7 |
MK-933; CD-5024; K-237 |
inhibitor of Impα/β1-mediated nuclear import; Antiviral towards HIV and the Dengue virus |
|
X |
|
|
|
New – 2025 |
| Ixekizumab |
|
Taltz |
IL-17A Inhibitor |
X |
|
|
|
|
|
| JAK Inhibitor 1 |
457081-03-7 |
CMP 6; Merck-5; Pyridone 6 |
JAK1 Inhibitor |
X |
|
|
|
|
|
| JNJ 10191584 Maleate |
869497-75-6 |
VUF6002; Compound 40 |
Histamine H4 Receptor Antagonist |
X |
|
|
|
|
|
| JNJ-10397049 |
708275-58-5 |
JNJ 10397049 |
Orexin Receptor Type 2 (OX2) Inhibitor |
X |
|
|
|
|
|
| JNJ-64619178 |
2086772-26-9 |
Onametostat |
PRMT5 Inhibitor |
X |
|
|
|
|
|
| JNK Inhibitor VIII |
894804-07-0 |
|
JNK Inhibitor |
X |
|
|
|
|
|
| JQ1 |
1268524-70-4 |
|
BET Inhibitor |
X |
X |
X |
|
|
|
| JWH-015 |
|
|
CB1/2 Agonist |
|
X |
|
|
|
|
| K252a |
|
|
Multikinase Inhibitor |
X |
|
|
|
|
|
| KD025 |
|
SLx-2119 |
ROCK2 Inhibitor |
X |
|
|
|
|
|
| Ketoconazole |
65277-42-1 |
Fungares; Ketoderm; Nizoral; Orifungal M; Panfungol |
Cytochrome P450 51 Inhibitor |
X |
|
|
|
|
|
| Ketoprofen |
22071-15-4 |
Actron |
COX Inhibitor |
X |
|
|
|
|
|
| Ketotifen Fumarate |
34580-14-8 |
Ketotifen; Ketotifeno; Ketotifenum; Zaditor |
Antihistamine Agent |
X |
|
|
|
|
|
| Ki16425 |
355025-24-0 |
Ki 16425 |
LPA1, LPA3 Receptor Inhibitor |
X |
|
|
|
|
|
| Kisspeptin-10 |
|
Metastatin |
KISS1 Agonist; GPR54 Agonist |
X |
|
|
|
|
|
| KN93 |
139298-40-1 |
|
CAMKII Inhibitor |
X |
X |
|
|
|
|
| KNK437 |
218924-25-5 |
|
Hsp Modulator; Hsp Inhibitor (Hsp 72, 73, 90, 105, 27, 40) |
X |
|
|
|
|
|
| L-744832 |
1177806-11-9 |
|
Farnesyltransferase Inhibitor |
X |
|
|
|
|
|
| Lansoprazole |
103577-45-3 |
A-65006; AG-1749; Prevacid |
Proton Pump Inhibitor |
X |
|
|
|
|
|
| Lapatinib |
388082-77-7 |
GW 572016; Lapatinib Ditosylate; Lapatinib Tosilate Hydrate; Tykerb |
Tyrosine Kinase Inhibitor (ERBB1, ERBB2) |
X |
|
|
|
|
|
| L-Arginine Hydrochloride |
1119-34-2 |
|
Vasodilator |
X |
|
|
|
|
|
| Larotrectinib |
1223403-58-4 |
Vitrakvi |
Tropomyosin Kinase Receptor (Trk) Inhibitor |
X |
|
|
|
|
|
| Leflunomide |
75706-12-6 |
Arava; Leflunomida; Leflunomidum; Lefunomide |
Dihydroorotate Dehydrogenase (DHODH) Inhibitor |
X |
|
X |
|
|
|
| Lenalidomide |
191732-72-6 |
Revlimid |
Immunomodulating Agent; Antineoplastic Agent |
X |
|
X |
|
|
|
| Lenvatinib |
417716-92-8 |
Lenvima |
Tyrosine Kinase Inhibitor |
X |
|
X |
|
|
|
| Letrozole |
112809-51-5 |
CGS 20267; Femara |
Cytochrome P450 19A1 Inhibitor |
X |
|
|
|
|
|
| Levamisole Hydrochloride |
14769-73-4 |
(-)-Tetramisole Hydrochloride; Ergamisol; Levamisole HCl; Tramisol |
Antihelminthic Agent |
X |
|
|
|
|
|
| LFM-A13 |
62004-35-7 |
|
BTK Inhibitor |
X |
|
|
|
|
|
| Linezolid |
165800-03-3 |
PNU 100766; Zyvox |
Antibiotic Agent |
X |
|
|
|
|
|
| Linsitinib |
867160-71-2 |
OSI-906 |
IGF-1R Inhibitor |
X |
|
|
|
|
|
| Liothyronine |
|
Liothyronin; Tresitope; Triiodothyronine |
Thyroid Hormone Receptor Agonist |
X |
|
|
|
|
|
| Liraglutide |
|
Liraglutida; Liraglutidum; Saxenda; Victoza |
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist |
X |
|
|
|
|
|
| Lithium Chloride |
7447-41-8 |
|
Inorganic Compound |
X |
X |
X |
X |
|
|
| Lofexidine Hydrochloride |
21498-08-8 |
Lucemyra |
α2A Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Lonafarnib |
193275-84-2 |
Sch66336 |
Ftase Inhbitor |
X |
|
|
|
|
|
| Lonidamine |
50264-69-2 |
Diclondazolic acid; Doridamina |
Hexokinase Inhibitor; Glycolysis Inhibitor |
X |
|
|
|
|
|
| Loperamide Hydrochloride |
34552-83-5 |
|
Opioid-receptor Agonist |
X |
|
|
|
|
|
| Lopinavir |
192725-17-0 |
A-157378.0; ABT-378; Aluviran; Koletra |
Antiretroviral Agent; Protease Inhibitor |
X |
|
|
|
|
|
| Lorlatinib |
|
|
ALK/ROS1 Inhibitor |
|
|
|
X |
|
|
| Lornoxicam |
70374-39-9 |
Chlortenoxicam; Xefo |
NSAID; Analgesic Agent; Anti-inflammatory Agent |
X |
|
|
|
|
|
| Loteprednol Etabonate |
82034-46-6 |
Alrex; Lotemax |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Lovastatin |
75330-75-5 |
Altoprev; Mevacor; Mevinolin |
HMG-CoA Reductase Inhibitor |
X |
|
|
|
|
|
| Loxapine Succinate |
27833-64-3 |
Adasuve; Loxitane |
Antipsychotic Agent |
X |
|
|
|
|
|
| LP99 |
|
|
Bromodomain Inhibitor |
X |
|
|
|
|
|
| LPS |
|
|
TLR4 Agonist |
X |
|
X |
X |
|
|
| Lumacaftor |
936727-05-8 |
VX-809 |
CFTR Modulator |
X |
|
|
|
|
|
| Luminespib |
747412-49-3 |
AUY-922; NVP-AUY922 |
Hsp90 Inhibitor |
X |
|
|
|
|
|
| lunresertib |
2719793-90-3 |
RP-6306 |
PKMYT1 Inhibitor |
X |
|
|
|
|
|
| LY294002 |
154447-36-6 |
|
CK2 Inhibitor; PI3K Inhibitor |
X |
|
X |
|
|
|
| LY3214996 |
1951483-29-6 |
Temuterkib |
ERK1/ERK2 Inhibitor |
X |
|
|
|
|
|
| Lysipressin |
50-57-7 |
Lysine vasopressin; [Lys8]-Vasopressin |
Activates Oxytocin receptors and adenylate-cyclase |
X |
|
|
|
|
New – 2025 |
| M344 |
251456-60-7 |
D237; Histone Deacetylase Inhibitor III; MS 344 |
HDAC Inhibitor |
X |
|
|
|
|
|
| M5N36 |
2832887-40-6 |
|
Cdc25C inhibitor |
X |
|
|
|
|
New – 2025 |
| Macitentan |
441798-33-0 |
Opsumit |
ET-A Inhibitor; ET-B Inhibitor |
X |
|
|
|
|
|
| Manidipine |
89226-50-6 |
Manyper |
Calcium Channel Blocker; Antihypertensive Agent |
X |
|
|
|
|
|
| Mavacamten |
1642288-47-8 |
MYK461; SAR439152 |
Cardiac Myosin activator |
X |
|
|
|
|
|
| MCC950 |
|
|
NLRP3 Inhibitor |
X |
|
|
|
|
|
| MCC950 sodium |
256373-96-3 |
CP-456773 sodium; CRID3 sodium salt |
NLRP3 Inhibitor |
X |
|
|
|
|
|
| MDV3100 |
915087-33-1 |
Enzalutamide; MDV-3100; Xtandi |
Androgen Receptor (AR) Inhibitor |
X |
|
|
|
|
|
| Meclocycline Sulfosalicylate |
73816-42-9 |
Meclan; Meclan Cream; Mecloderm; Meclutin |
Antibiotic Agent |
X |
|
|
|
|
|
| Medetomidine Hydrochloride |
86347-15-1 |
Domitor; MPV 785; Medetomidine |
α2 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Medrysone |
2668-66-8 |
HMS; Hydroxymesterone |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Mefenamic Acid |
61-68-7 |
CI-473; Ponstel |
COX Inhibitor |
X |
|
|
|
|
|
| Megestrol Acetate |
595-33-5 |
Megace; Megestrol; Ovarid |
Progesterone Receptor (PR) Agonist |
X |
|
|
|
|
|
| Menadione |
58-27-5 |
Vitamin K3 |
Phosphatase Inhibitor; Mitochondrial DNA Polymerase γ (pol γ) Inhibitor |
X |
|
|
|
|
|
| Mepivacaine Hydrochloride |
1722-62-9 |
Carbocaina; Meaverin; Mepivastesin |
Sodium Channel α Subunit Blocker; Topical Anesthetic Agent |
X |
|
|
|
|
|
| Mequinol |
150-76-5 |
4-Methoxyphenol; MEHQ |
Depigmentation Agent |
X |
|
|
|
|
|
| Mesoridazine Besylate |
5588-33-0 |
Benzenesulfonate; Mesoridazine |
Antipsychotic Agent |
X |
|
|
|
|
|
| Metaproterenol Sulfate |
5874-97-5 |
Alupent; Metaprel; Orciprenaline |
β2 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Metformin Hydrochloride |
657-24-9 |
Haurymellin; Metformina; Metformine Pamoate; Metforminum |
AMPK Activator; Antihyperglycemic Agent |
X |
|
|
|
|
|
| Methacholine Chloride |
|
Acetyl-beta-methylcholine Chloride; Amechol; Mecholyl Chloride; Methacholine; Provocholine |
Muscarinic Acetylcholine Receptor Agonist |
X |
|
|
|
|
|
| Methacycline |
3963-95-9 |
AN100226, BG00002 |
Inhibitor of epithelial-to-mesenchymal transition EMT |
X |
|
|
|
|
New – 2025 |
| Methapyrilene Hydrochloride |
135-23-9 |
Capathyn; Histadyl; Methacon; Methapyrilene; Methoxylene |
Antihistamine Agent |
X |
|
|
|
|
|
| Methazolamide |
554-57-4 |
Naptazane; Neptazane; Neptazaneat |
Carbonic Anhydrase Inhibitor |
X |
|
|
|
|
|
| Methocarbamol |
532-03-6 |
Delaxin; Forbaxin; Miolaxin; Neuraxin; Robaxin |
Muscle Relaxer |
X |
|
|
|
|
|
| Methotrexate |
59-05-2 |
Abitrexate; Amethopterin; Emtexate; Ledertrexate; MTX; Metoject; Otrexup; Rasuvo |
Dihydrofolate Reductase (DHFR) Inhibitor |
X |
|
X |
X |
|
|
| Methyclothiazide |
135-07-9 |
|
Diuretic; Antihypertensive Agent |
X |
|
|
|
|
|
| Methyldopa |
555-30-6 |
Aldomet; Alphamethyldopa; Dopamet; Medomet |
α2 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Methylene Blue |
61-73-4 |
|
NOS Inhibitor; Guanylate Cyclase Inhibitor |
X |
|
|
|
|
|
| Mevastatin |
73573-88-3 |
Compactin |
HMG-CoA Reductase Inhibitor |
X |
|
|
|
|
|
| Mianserine Hydrochloride |
21535-47-7 |
Bolvidon; Lerivon; Tolvon |
H1 Receptor Inhibitor; Antidepressant |
X |
|
|
|
|
|
| Mifamurtide |
83461-56-7 |
Mepact; Mifamurtide Hydrate |
NOD2 Activator |
X |
|
|
|
|
|
| Milrinone |
78415-72-2 |
|
PDE3 Inhibitor |
X |
|
|
|
|
|
| Mitapivat |
1260075-17-9 |
AG-348 |
Pyruvate kinase allosteric activator |
X |
|
|
|
|
New – 2025 |
| Mitoglitazone |
146062-49-9 |
CAY10415 |
Insulin Sensitizer |
X |
X |
|
|
|
|
| Mitoxantrone |
|
Novantrone |
TOPO II Inhibitor; Antineoplastic Agent |
X |
|
|
|
|
|
| Mizolastine |
108612-45-9 |
Mizollen |
H1 Receptor Inhibitor |
X |
|
|
|
|
|
| Mizoribine |
50924-49-7 |
Bredinin |
Immunosuppressive Agent; DNA Synthesis Inhibitor |
X |
|
|
|
|
|
| MK-2206 |
1032350-13-2 |
|
AKT Inhibitor |
X |
|
|
|
|
|
| MK-8353 |
1184173-73-6 |
SCH900353 |
ERK1/ERK2 Inhibitor |
X |
|
|
|
|
|
| MK-8457 |
|
|
SYK Inhibitor |
X |
|
|
|
|
|
| MLN8054 |
869363-13-3 |
|
Aurora Kinase Inhibitor |
X |
|
X |
|
|
|
| Momelotinib |
|
CYT-387; GS-0387 |
JAK1/2 Inhibitor |
X |
X |
|
|
|
|
| Mometasone Furoate |
83919-23-7 |
Asmanex; Elomet; Nasonex |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Monensin Sodium |
22373-78-0 |
Coban; Rumensin |
Na+ Ionophore |
X |
|
|
|
|
|
| Monobenzone |
103-16-2 |
Benoquin; MBEH |
Skin Whitening Agent |
X |
|
|
|
|
|
| Monomethyl Fumarate |
2756-87-8 |
|
GPR109A Agonist |
X |
|
|
|
|
|
| Montelukast |
158966-92-8 |
MK 0476; MK-0476; Singulair |
CysLT1 Receptor Inhibitor; GPCR Ligand |
X |
|
|
|
|
|
| Mosapride Citrate |
112885-42-4 |
AS-4370; DSSTox_CID_26207; Gasmotin |
5-HT4 Receptor Agonist |
X |
|
|
|
|
|
| Motilin |
|
|
Motilin Receptor Agonist |
X |
|
|
|
|
|
| Moxifloxacin Hydrochloride |
186826-86-8 |
Avalox; Avelox; Moxeza; Vigamox |
Antimicrobial Agent |
X |
|
|
|
|
|
| MRL-SYKi |
|
DRX_MRL-SYKi |
SYK Inhibitor |
X |
|
|
|
|
|
| MRT67307 |
1190378-57-4 |
|
IKKε, MARK1-4, NUAK1 , TBK-1 Inhibitor |
X |
X |
|
|
|
|
| Mycophenolic Acid |
24280-93-1 |
Cellcept; Melbex; Mycophenolate; Mycophenolsaeure; Myfortic |
IMPDH Inhibitor |
X |
|
|
|
|
|
| Myxothiazol |
76706-55-3 |
|
Cytochrome c Reductase Inhibitor; Mitochondrial Inhibitor |
X |
|
|
|
|
|
| MZ1 |
1797406-69-9 |
|
BRD4 PROTAC |
X |
|
|
|
|
|
| N-Acetyl Cysteine |
616-91-1 |
616-91-1; Acetadote; Acetylcysteine; Fluimucil; N-Acetylcysteine |
Antioxidant |
X |
X |
|
|
|
|
| Nafcillin Sodium Monohydrate |
985-16-0 |
6-(2-Ethoxy-1-naphthamido)penicillin |
Antibiotic Agent |
X |
|
|
|
|
|
| Nalmefene Hydrochloride |
58895-64-0 |
Nalmetrene |
Opioid Receptor Inhibitor |
X |
|
|
|
|
|
| Naproxen |
22204-53-1 |
Anaprox; Naprelan; Naprolag; Naprosyn |
COX Inhibitor |
X |
|
|
|
|
|
| Natalizumab |
189261-10-7 |
|
Binds to α4β1-integrin and blocks its interaction |
|
|
|
|
X |
New – 2025 |
| Natalizumab |
189261-10-7 |
AN100226, BG00002 |
Antibody binds to α4β1-integrin that blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1) |
X |
|
|
|
|
New – 2025 |
| Navitoclax |
923564-51-6 |
ABT-263 |
Bcl-2 Inhibitor |
X |
|
X |
|
|
|
| Navoximod |
1402836-58-1 |
GDC-0919; NLG-919; NLG919; RG6078 |
IDO Inhibitor |
X |
|
X |
X |
|
|
| Nebivolol |
152520-56-4 |
Bystolic; Lobivon; Nebilet; Nebivololum; R 67555 |
β1 Adrenergic Receptor Inhibitor |
X |
|
|
|
|
|
| Nefazodone |
83366-66-9 |
Nefazodona; Nefazodone Hydrochloride; Nefazodonum |
Antidepressant Agent; 5-HT2A Inhibitor |
X |
|
|
|
|
|
| Neflamapomid |
209410-46-8 |
VX 745; VX745 |
p38 MAPK Inhibitor |
X |
|
X |
|
|
|
| Nefopam Hydrochloride |
23327-57-3 |
Acupan; Ajan; Nefadol; Silentan |
Non-opioid Analgesic Drug |
X |
|
|
|
|
|
| Nelarabine |
121032-29-9 |
Arranon |
DNA Inhibitor |
X |
|
|
|
|
|
| Neomycin Sulfate |
1405-10-3 |
Fradiomycin; Framycetin; Mycifradin; Soframycin |
Antibiotic Agent |
X |
|
|
|
|
|
| Neostigmine Bromide |
114-80-7 |
Eustigmin Bromide; Neo-Proserin; Neoserine Bromide; Proserine Bromide; Prostigmin |
Acetylcholinesterase Inhibitor |
X |
|
|
|
|
|
| Nerandomilast |
1423719-30-5 |
BI 1015550 |
PDE4B Inhibitor |
X |
X |
|
|
|
|
| Neuromedin B |
|
Beta-Neurokinin; Neuromedin K; Porcine Neurokinin B |
NMBR Agonist |
X |
|
|
|
|
|
| NI-57 |
|
GTPL8573 |
Bromodomain Inhibitor |
X |
|
|
|
|
|
| Nialamide |
51-12-7 |
Niamid; Niamide; Nuredal; Surgex |
Monoamine Oxidase Inhibitor (MAOI) |
X |
|
|
|
|
|
| Nifuroxazide |
965-52-6 |
RC-27109; SJ000287313 |
STAT Inhibitor |
X |
|
|
|
|
|
| Nigericin sodium salt |
28643-80-3 |
|
Antibiotic Agent / NLRP3 Activator |
X |
|
|
|
|
|
| Nintedanib |
656247-17-5 |
BIBF 1120; Ofev; Vargatef |
VEGFR, FGFR, PDGFR Kinase Inhibitor |
X |
X |
|
|
|
|
| Nirogacestat |
1290543-63-3 |
PF-3084014 |
γ-secretase inhibitor |
X |
|
|
|
|
|
| Nithiamide |
140-40-9 |
Acinitrazole; Aminitrozole |
Antimicrobial Agent |
X |
|
|
|
|
|
| Nitrofural |
59-87-0 |
Furacilin; Furacin; Nitrofurazone |
Antibiotic Agent |
X |
|
|
|
|
|
| Nitroprusside |
13755-38-9 |
Nipride; Nitroferricyanide; Nitropress |
Vasodilator |
X |
|
|
|
|
|
| Nitroxoline |
4008-48-4 |
8-Hydroxy-5-nitroquinoline |
Antimicrobial agent; Anticancer agent |
X |
|
|
|
|
New – 2025 |
| Nivolumab |
946414-94-4 |
Opdivo |
PD-1 Inhibitor |
X |
|
X |
X |
|
|
| Nodinitib-1 |
799264-47-4 |
CID-1088438; ML130 |
NOD1 Inhibitor |
X |
|
|
|
|
|
| Norethindrone |
68-22-4 |
Norethisterone; Utovlan |
Progesterone Receptor (PR) Agonist |
X |
|
|
|
|
|
| Nortriptyline Hydrochloride |
72-69-5 |
Ateben; Avantyl; Demethylamitriptyline; Noritren; Psychostyl; Sensaval |
SNRI |
X |
|
|
|
|
|
| Nutlin-3 |
|
|
MDM2 Antagonist |
|
X |
X |
|
|
|
| NVP-TAE684 |
761439-42-3 |
NVP-TAE 684; TAE684 |
ALK Inhibitor; Kinase Modulator |
X |
|
|
|
|
|
| NVS1-PAK1-1 |
|
DRX_NVS1-PAK1-1 |
PAK1 Inhibitor |
X |
|
|
|
|
|
| Obeticholic Acid |
|
|
FXR Agonist |
|
X |
|
|
|
|
| Octadecanoic acid |
57-11-4 |
|
Organic Compound |
X |
|
|
|
|
|
| Odanacatib |
603139-19-1 |
MK0822 |
Cathepsin K Inhibitor |
X |
X |
|
|
|
|
| Odevixibat |
501692-44-0 |
A4250 |
Inhibitor of the ileal bile acid transporter (IBAT) |
X |
|
|
|
|
New – 2025 |
| ODN2006 |
|
|
TLR9 Agonist |
X |
|
|
|
X |
|
| ODN2395 |
|
|
TLR9 Agonist |
X |
|
|
|
|
|
| OEA |
|
Oleoylethanolamine |
PPARα Agonist |
X |
|
|
|
|
|
| Ofloxacin |
82419-36-1 |
Floxin; Ocuflox; Ofloxacine; Tarivid |
Antimicrobial Agent |
X |
|
|
|
|
|
| Olaparib |
763113-22-0 |
AZD 2281; AZD-2281; Lynparza |
PARP Inhibitor |
X |
|
X |
X |
|
|
| Olcegepant |
204697-65-4 |
BIBN-4096; BIBN 4096BS |
antagonist of the calcitonin gene-related peptide 1 receptor |
|
|
|
|
X |
New – 2025 |
| Oligomycin A |
579-13-5 |
MCH 32 |
F0/F1 ATPase Inhibitor; Mitochondrial Inhibitor |
X |
|
X |
|
|
|
| Olmutinib |
1353550-13-6 |
BI-1482694 |
Tyrosine Kinase Inhibitor |
X |
|
X |
X |
|
|
| Omaveloxolone |
1474034-05-3 |
RTA 408 |
STING Inhibitor |
X |
|
|
|
|
|
| Omecamtiv Mecarbil |
873697-71-3 |
CK-1827452 |
Cardiac Myosin activator |
X |
|
|
|
|
|
| Omeprazole |
73590-58-6 |
Antra; H-168/68; Prilosec |
Proton Pump Inhibitor |
X |
|
|
|
|
|
| Omipalisib |
1086062-66-9 |
GSK-2126458; GSK2126458 |
PI3K Inhibitor; mTOR Inhibitor |
X |
X |
X |
X |
|
|
| ONC201 |
|
|
DRD2 Inhibitor |
X |
|
|
X |
|
|
| Oncostatin M |
106956-32-5 |
|
LIFR-α; OSMR Agonist |
X |
|
|
|
|
|
| Ondansetron Hydrochloride |
99614-02-5 |
Zofran |
Antinausea Agent |
X |
|
|
|
|
|
| ONX 0914 |
960374-59-8 |
PR-957 |
Immunoproteasome Inhibitor |
X |
|
|
|
|
|
| Orforglipron |
2212020-52-3 |
LY3502970, GLP-1 agonist |
GLP-1 agonist |
|
X |
|
|
|
New – 2025 |
| Orforglipron |
2212020-52-3 |
LY3502970; GLP-1 receptor agonist 1 |
GLP-1 agonist |
X |
|
|
|
|
New – 2025 |
| ORIC-944 |
2369769-29-7 |
Rinzimetostat |
Allosteric inhibitor targeting the EED subunit of PRC2 |
X |
|
|
|
|
New – 2025 |
| Orlistat |
96829-58-2 |
Alli; Xenical |
PI3K Inhibitor; mTOR Inhibitor |
X |
|
|
|
|
|
| Osimertinib |
1421373-65-0 |
AZD9291; Mereletinib |
EGFR Inhibitor |
X |
|
X |
X |
|
|
| OTX015 |
202590-98-5 |
MK-8628 |
BET Inhibitor |
X |
X |
|
X |
X |
|
| Oxaliplatin |
61825-94-3 |
Diaminocyclohexane Oxalatoplatinum; Eloxatin; L-OHP |
Antineoplastic Agent; DNA Synthesis Inhibitor |
X |
|
X |
|
|
|
| Oxaprozin |
21256-18-8 |
Alvo; Daypro; Deflam; Oxaprozine |
COX Inhibitor |
X |
|
|
|
|
|
| Oxethazaine |
126-27-2 |
Betalgil; Mucaine; Oxaethacainum; Oxetacaine |
Local Anaesthetic |
X |
|
|
|
|
|
| Oxibendazole |
20559-55-1 |
|
Polymerase Inhibitor |
X |
|
|
|
|
|
| Oxybuprocaine Hydrochloride |
5987-82-6 |
Benoxinate Hydrochloride |
Sodium Channel α Subunit Blocker; Topical Anesthetic Agent |
X |
|
|
|
|
|
| Oxybutynin Chloride |
1508-65-2 |
Ditropan; Oxibutinina; Oxibutyninum; Oxybutynin; Oxytrol |
Muscarinic Acetylcholine Receptor (mAChR) Inhibitor |
X |
|
|
|
|
|
| Ozagrel Hydrochloride |
78712-43-3 |
Sodium Ozagrel; UNII-L256JB984D |
Antiplatelet Agent; Thromboxane A2 Synthesis (TXAS) Inhibitor |
X |
|
|
|
|
|
| Ozanimod |
1306760-87-1 |
RPC-1063 |
S1P Receptor Agonist |
X |
|
|
|
|
|
| P22077 |
|
DUB Inhibitor |
USP47 Inhibitor |
X |
|
|
|
|
|
| P7C3 |
301353-96-8 |
AK340958 |
NAMPT Activator; Proneurogenic; Neuroprotective |
X |
|
|
|
|
|
| Paclitaxel |
33069-62-4 |
Anzatax; Asotax; Bristaxol; Praxel; Taxol; Taxol Konzentrat |
Microtubule Disruptor |
X |
|
X |
X |
|
|
| Palbociclib |
827022-33-3 |
Ibrance; PD0332991 |
CDK4/6 Inhibitor |
X |
|
X |
X |
|
|
| Paliperidone |
144598-75-4 |
Invega |
Dopamine (D2) Receptor Inhibitor; 5-HT2A Receptor Inhibitor |
X |
|
|
|
|
|
| Palonosetron Hydrochloride |
135729-62-3 |
Aloxi |
5-HT3A Receptor Inhibitor |
X |
|
|
|
|
|
| Pam3CSK4 |
|
|
TLR1/TLR2 Agonist |
X |
|
|
|
|
|
| Pamoic Acid Disodium |
6640-22-8 |
Embonic Acid |
GPR35 Agonist |
X |
|
|
|
|
|
| Pamrevlumab |
946415-13-0 |
FG-3019 |
Anti-CTGF |
|
|
|
|
|
|
| Panitumumab |
|
ABX-EGF; Vectibix |
EGFR Inhibitor |
X |
|
X |
XZ |
|
|
| Panobinostat |
404950-80-7 |
Faridak; Farydak; LBH-589; LBH589 |
HDAC Inhibitor |
X |
|
|
|
|
|
| Paromomycin Sulfate |
1263-89-4 |
Aminosidine Sulfate; Humatin; Paromomycin; Paromomycin Sulfate Salt |
Antibiotic Agent |
X |
|
|
|
|
|
| Paroxetine Hydrochloride |
110429-35-1 |
Aropax 20; Paroxat; Paroxetine Hcl |
SSRI |
X |
|
|
|
|
|
| Pazopanib |
444731-52-6 |
GW 78603; GW786034; Pazopanibum; Votrient |
Multi Tyrosine Kinase Receptor Inhibitor (c-KIT, FGFR, PDGFR, VEGFR) |
X |
X |
|
|
|
|
| PBI-4050 |
|
|
Antifibrotic Agent |
X |
X |
|
|
|
|
| PD098059 |
167869-21-8 |
|
MEK Inhibitor |
X |
|
|
|
|
|
| PD123319 |
130663-39-7 |
|
Angiotensin II (AT2) Receptor Inhibitor |
X |
|
|
|
|
|
| PD184352 |
212631-79-3 |
CI-1040 |
MEK Inhibitor |
X |
|
|
|
X |
|
| PDGF-BB |
|
|
PDGFRβ Activator |
X |
|
|
|
|
|
| Pembrolizumab |
|
Keytruda |
PD-1 Inhibitor |
X |
|
X |
X |
|
|
| Pemetrexed Disodium |
150399-23-8 |
|
Dihydrofolate Reductase (DHFR) Inhibitor; GAR Transformylase Inhibitor; Thymidylate Synthase Inhibitor |
X |
|
X |
X |
|
|
| Pemigatinib |
1513857-77-6 |
INCB054828 |
FGFR Inhibitor |
X |
X |
X |
|
|
|
| Penciclovir |
39809-25-1 |
Denavir |
Guanosine Analogue; Antiviral Agent |
X |
|
|
|
|
|
| Pentamidine |
50357-45-4 |
Nebupent; Pentam |
Antimicrobial Agent |
X |
|
|
|
|
|
| Perfluorodecanoic acid |
335-76-2 |
PFDA |
Reduces mRNA expression of the genes |
X |
|
|
|
|
New – 2025 |
| Pergolide Mesylate |
66104-23-2 |
Pergolide; Pergolide Methanesulfonate; Permax |
Dopamine Receptor Agonist |
X |
|
|
|
|
|
| Perindopril Erbumine |
107133-36-8 |
Aceon |
Angiotensin-converting Enzyme Inhibitor |
X |
|
|
|
|
|
| Pertuzumab |
|
2C4 Antibody; MOAB 2C4; Omnitarg; Perjeta; rhuMAb-2C4 |
HER2 Dimerization Inhibitor |
X |
|
|
|
|
|
| PF-04217903 |
956905-27-4 |
|
c-Met Inhibitor |
X |
|
|
|
|
|
| PF-06297470 |
|
|
mGluR5 Inhibitor |
X |
|
|
|
|
|
| PF-06650833 |
1817626-54-2 |
|
IRAK4 Inhibitor |
X |
|
|
|
|
|
| PFI-1 |
1403764-72-6 |
PF-06405761; PF-6405761 |
BET Inhibitor |
X |
X |
X |
|
|
|
| PFI-3 |
|
|
SMARCA2/4 Inhibitor; Polybromo 1 (PBRM1) Inhibitor |
X |
|
X |
|
|
|
| PFI-4 |
|
PFI4 |
Bromodomain Inhibitor |
X |
|
|
|
|
|
| PHA-408 |
503555-55-3 |
|
IKK2 Inhibitor |
X |
|
|
|
|
|
| Phenazopyridine Hydrochloride |
136-40-3 |
Bisteril; Mallophene; Phenazopyridine HCl; Urodine |
Sodium Channel α Subunit Blocker; Topical Anesthetic Agent |
X |
|
|
|
|
|
| Pheniramine Maleate |
132-20-7 |
Avil-retard; Daneral; Inhiston; Naphcon; Trimetose |
Antihistamine Agent |
X |
|
|
|
|
|
| Phenylbutazone |
50-33-9 |
Butatron; Butazolidin |
COX Inhibitor |
X |
|
|
|
|
|
| Phenylephrine |
|
Cyclomydril; Mydfrin |
α1 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Phorbol 12-myristate 13-acetate |
16561-29-8 |
PMA |
PKC Activator |
X |
|
|
|
|
|
| Piclamilast |
144035-83-6 |
Cpodpmb; RP 73401 |
PDE4 Inhibitor |
X |
|
|
|
|
|
| Picropodophyllin |
477-47-4 |
AXL1717; Picropodophyllotoxin |
Microtubule Disruptor |
X |
|
|
|
|
|
| PIM447 |
1210608-43-7 |
LGH447 |
PIM Kinase Inhibitor |
X |
|
|
|
|
|
| Pimasertib |
1236699-92-5 |
AS 703026; AS703026 |
MEK Inhibitor |
X |
|
|
|
|
|
| Pimobendan |
74150-27-9 |
Vetmedin |
PDE3 Inhibitor |
X |
|
|
|
|
|
| Pioglitazone |
111025-46-8 |
Actos; Glustin; Pioglitazona; Pioglitazonum |
PPARγ Agonist |
X |
|
|
|
|
|
| Pirfenidone |
53179-13-8 |
Esbriet; Etuary; KitosCell; Pirespa; Pirfenex |
Antifibrotic Agent |
X |
X |
|
|
|
|
| Pironetin |
151519-02-7 |
|
Microtubule Disruptor |
X |
|
|
|
|
|
| Pirtobrutinib |
2101700-15-4 |
LOXO-305 |
BTK Inhibitor |
X |
|
|
|
|
|
| Pitolisant |
362665-56-3 |
Tiprolisant |
Histamine H3 Receptor Inverse Agonist |
X |
|
|
|
|
|
| Pizotifen Malate |
|
Pizotyline; Sandomigran |
5-HT Receptor Antagonist |
X |
|
|
|
|
|
| PKN1/2-IN-1 |
942425-34-5 |
|
Cell penetrant and selective PKN2 (PRK2) inhibitor |
X |
X |
|
|
|
New – 2025 |
| Pladienolide B |
445493-23-2 |
|
Spliceosome Inhibitor |
X |
|
X |
X |
|
|
| Plerixafor |
155148-31-5 |
AMD 3100 |
CXCR4 Inhibitor |
X |
X |
|
|
X |
|
| PLX4720 |
918505-84-7 |
PLX-4720 |
BRAF Inhibitor |
X |
|
|
|
|
|
| PNU 74654 |
113906-27-7 |
|
Wnt/β-catenin Pathway Inhibitor |
X |
|
|
|
|
|
| Poly(I:C)HMW |
|
|
TLR3 Agonist |
X |
|
|
|
X |
|
| Pomalidomide |
19171-19-8 |
3-amino Thalidomide; CC-4047 |
Immunomodulating Agent; Antineoplastic Agent |
X |
|
|
|
|
|
| Ponatinib |
|
3-amino Thalidomide; AP 24534; AP24534; Iclusig |
BCR-ABL Inhibitor |
X |
X |
|
|
|
|
| Posaconazole |
171228-49-2 |
Noxafil; Sch 56592 |
CYP51 Inhibitor |
X |
|
|
|
|
|
| PP1 |
172889-26-8 |
Mutant Kinases Inhibitor II; PP1 Analog II |
Src Family Inhibitor |
X |
|
|
|
|
|
| PP242 |
1092351-67-1 |
PP 242 |
mTOR Inhibitor |
X |
|
|
|
|
|
| Pralatrexate |
146464-95-1 |
Folotyn |
DHFR Inhibitor |
X |
|
|
|
|
|
| Pralsetinib |
2097132-94-8 |
BLU-667 |
RET Inhibitor |
X |
|
X |
|
X |
|
| Pramlintide |
151126-32-8 |
|
High affinity for amylin, CGRP and calcitonin receptors |
X |
|
|
|
|
New – 2025 |
| Pramoxine Hydrochloride |
637-58-1 |
|
Topical Anesthetic |
X |
|
|
|
|
|
| Pranlukast |
103177-37-3 |
Onon |
Cysteinyl Leukotriene Receptor 1 (CYSLTR1) Antagonist |
X |
|
|
|
|
|
| Praziquantel |
55268-74-1 |
Biltricide |
Antimicrobial Agent |
X |
|
|
|
|
|
| Prednisolone |
50-24-8 |
Hydroretrocortine; Metacortandralone; Millipred; Omnipred; Orapred; PRDL; Pediapred; Prednisolona |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
X |
|
| Prednisone |
53-03-2 |
Adasone; Dehydrocortisone; Deltasone; Meticorten; Prednisonum |
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Pregnenolone sulfate sodium salt |
1852-38-6 |
3β-Hydroxy-5-pregnen-20-one monosulfate sodium |
Inhibitor of cannabinoid CB1 receptor |
X |
|
|
|
|
New – 2025 |
| Prilocaine Hydrochloride |
721-50-6 |
Citanest |
Anaesthetic Agent |
X |
|
|
|
|
|
| Primaquine Diphosphate |
90-34-6 |
NSC 149765; Tronolane |
Quinone Reductase 2 Inhibitor |
X |
|
|
|
|
|
| Probenecid |
57-66-9 |
Benecid; Benemid; Probalan; Probecid; Probenecid Acid |
Uricosuric Agent |
X |
|
|
|
X |
|
| Procarbazine Hydrochloride |
671-16-9 |
Matulane; Nathulane; Natunalar; PROCARBAZINE HCl |
Antineoplastic Agent |
X |
|
|
|
|
|
| Progesterone |
57-83-0 |
Prometrium |
Progesterone Receptor (PR) Agonist |
X |
|
|
|
|
|
| Prostaglandin D2 |
41598-07-6 |
PGD2 |
DP Agonist |
X |
|
|
|
|
|
| Prostaglandin E2 |
363-24-6 |
Cervidil; Dinoprostone; Prepidil; Prostin E2 |
EP Agonist |
X |
|
|
|
|
|
| PrRP-31 |
|
Prolactin Releasing Peptide-31 |
hGR3/GPR10 Agonist |
X |
|
|
|
|
|
| PRT062607 |
|
PRT-062607 |
Syk Inhibitor |
X |
|
|
|
|
|
| Psilocybin |
2641522-10-1 |
|
Tryptamine, hallucinogenic |
X |
X |
X |
|
X |
New – 2025 |
| Pyridostigmine Bromide |
101-26-8 |
Kalimin; Mestinon; Mestinon Bromide; Regonol |
Cholinesterase Inhibitor |
X |
|
|
|
|
|
| Pyrithioxin |
1098-97-1 |
1098-97-1; Bonifen; Encefabol; Pyrithioxine; Pyritinol |
Neurotropic Agent |
X |
|
|
|
|
|
| QRFP-26 |
|
P518 |
GPR 103 Agonist |
X |
|
|
|
|
|
| Quinacrine Dihydrochloride Dihydrate |
83-89-6 |
Atabrine Hydrochloride |
PLA2 (phophoslipase A2) Inhibitor |
X |
|
|
|
|
|
| Quizartinib |
950769-58-1 |
AC220 |
FLT3 Inhibitor |
X |
|
|
|
|
|
| R(-)rolipram |
85416-73-5 |
Adeo; Rolipramum; ZK 62711 |
PDE4 Inhibitor |
X |
|
|
|
|
|
| RA11740397 (MLI2) |
|
|
LRRK2 Inhibitor |
X |
|
|
|
|
|
| Radicicol |
12772-57-5 |
Monorden |
HSP90 Inhibitor |
X |
X |
|
|
|
|
| Raltitrexed |
112887-68-0 |
Tomudex; ZD1694 |
Dihydrofolate Reductase Inhibitor; Thymidylate Synthase Inhibitor |
X |
|
|
|
|
|
| Rapamycin |
53123-88-9 |
AY 22989; Rapamune; SILA 9268A; Sirolimus; WY-090217 |
mTOR Inhibitor |
X |
X |
X |
X |
|
|
| RDEA119 |
923032-37-5 |
BAY 869766; RDEA-119; Refametinib |
MEK Inhibitor |
X |
|
|
|
|
|
| Reboxetine Mesylate |
98769-84-7 |
|
Noradrenalin Uptake Inhibitor |
X |
|
|
|
|
|
| Regorafenib |
755037-03-7 |
BAY 73-4506 |
Multikinase Inhibitor (VEGFR2-TIE2 Tyrosine Kinase) |
X |
|
|
|
|
|
| Remdesivir |
1809249-37-3 |
GS-5734 |
Nucleoside Analogue |
X |
|
|
|
|
|
| Repaglinide |
135062-02-1 |
GlucoNorm; NovoNorm; Prandin; Repaglinidum |
Antidiabetic Agent |
X |
|
|
|
|
|
| Resatorvid |
243984-11-4 |
TAK-242, CLI-095 |
Toll-like receptor 4 (TLR4) inhibitor |
X |
|
|
|
|
New – 2025 |
| Resiquimod |
144875-48-9 |
|
TLR7/TLR8 Agonist |
X |
|
|
|
|
|
| Resmetirom |
920509-32-6 |
MGL-3196, VIA-3196 |
TRH Receptor B-Agonist |
X |
X |
|
|
|
New – 2025 |
| Resveratrol |
501-36-0 |
|
CYP1A1 Inhibitor |
X |
X |
|
|
|
|
| Retapamulin |
224452-66-8 |
Altabax; Altargo |
Antimicrobial Agent |
X |
|
|
|
|
|
| Retinol |
68-26-8 |
|
Vitamin A |
X |
|
|
|
|
|
| rhM-CSF |
Not Listed |
Recombinant Human Macrophage-colony Stimulating Factor |
M-CSF Receptor Agonist |
X |
|
|
|
|
|
| Ribociclib |
1211441-98-3 |
LEE01 |
CDK4/6 Inhibitor |
X |
|
|
|
|
|
| Rimonabant |
158681-13-1 |
SR141716 |
CB1 Inverse Agonist; GPCR Ligand |
X |
|
|
|
|
|
| Riociguat |
625115-55-1 |
Adempas |
sGC Activator |
|
X |
|
|
|
|
| Risdiplam |
1825352-65-5 |
RG7916; RO7034067 |
SMN2 pre-mRNA splicing modifier |
X |
|
|
|
|
New – 2025 |
| Risedronate Sodium |
115436-72-1 |
Actonel; Atelvia; Benet |
Biphosphonate; Bone Density Conservation Agent |
X |
|
|
|
|
|
| Ritlecitinib |
1792180-81-4 |
PF-06651600 |
JAK3 inhibitor |
X |
|
|
|
|
New – 2025 |
| Ritonavir |
155213-67-5 |
A-84538; ABT-53; ABT-538; Abbott 84538; Norvir |
HIV Protease Inhibitor |
X |
|
|
|
|
|
| RN486 |
1242156-23-5 |
|
BTK Inhibitor |
X |
|
|
|
|
|
| Ro 106-9920 |
62645-28-7 |
|
Ubiquitin Ligase Inhibitor |
X |
|
|
|
|
|
| Ro 20-1724 |
29925-17-5 |
|
PDE4 Inhibitor |
X |
|
|
|
|
|
| Ro 320-1195 |
Not Listed |
|
p38 MAPK Inhibitor |
X |
|
|
|
|
|
| Ro 32-0432 |
151342-35-7 |
|
PKC (c+n) Inhibitor |
X |
|
|
|
|
|
| Ro 5126766 |
946128-88-7 |
RO5126766 |
BRAF Inhibitor; MEK Inhibitor |
X |
|
|
|
|
|
| Rofecoxib |
162011-90-7 |
Ceoxx; MK 966; Vioxx |
COX-2 Inhibitor |
X |
|
|
|
X |
|
| Roflumilast |
162401-32-3 |
Daliresp; Daxas; ROF; Roflumilastum |
PDE4 Inhibitor |
X |
X |
|
|
|
|
| Roflumilast N-Oxide |
292135-78-5 |
|
PDE4 Inhibitor |
X |
X |
|
|
|
|
| Rolipram |
61413-54-5 |
Adeo; Rolipramum; ZK 62711 |
PDE4 Inhibitor |
X |
|
|
|
|
|
| Romidepsin |
128517-07-7 |
FK 228 |
HDAC Inhibitor |
X |
|
|
|
|
|
| Rosiglitazone |
122320-73-4 |
TZD; Avandia |
PPARγ Agonist |
X |
X |
X |
|
|
|
| Rosuvastatin |
287714-41-4 |
Rosuvastatin; Crestor |
HMG-CoA Reductase Inhibitor |
X |
|
|
|
|
|
| Rotenone |
83-79-4 |
Barbasco; Dactinol; Paraderil; Tubatoxin |
Mitochondrial Inhibitor; NADH Dehydrogenase Inhibitor |
X |
|
|
|
|
|
| Roxadustat |
Not Listed |
FG-4592 |
HIF-PHI Inhibitor |
X |
|
|
|
|
|
| Rucaparib Phosphate |
459868-92-9 |
|
PARP Inhibitor |
|
X |
|
|
|
|
| Ruxolitinib |
941678-49-5 |
INCB018424; Jakafi |
JAK1/2 Inhibitor |
X |
X |
X |
|
X |
|
| RVU120 |
1609452-30-3 |
SEL120; SEL120-34A |
CDK8 Inhibitor |
X |
X |
|
|
|
|
| RXDX-106 |
Not Listed |
|
TAM Receptor Inhibitor |
X |
|
|
|
|
|
| R-α-Methylhistamine |
6986-90-9 |
|
H3 Histamine Receptor Agonist |
X |
|
|
|
|
|
| S31-201 |
501919-59-1 |
Nsc 74859 |
STAT3 Inhibitor |
X |
|
|
|
|
|
| Salbutamol Sulfate |
51022-70-9 |
Albuterol |
β2 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Salicylanilide |
87-17-2 |
2-Hydroxybenzanilide; N-Phenylsalicylamide |
Antimicrobial Agent |
X |
|
|
|
|
|
| Salicylic Acid |
69-72-7 |
2-Carboxyphenol; 2-Hydroxybenzoic acid; O-hydroxybenzoic acid |
COX Inhibitor |
X |
|
|
|
|
|
| Salinomycin Monosodium |
55721-31-8 |
Coxistac; Salinomycin |
P-glycoprotein 1 Inhibitor |
X |
|
|
|
|
|
| Salmeterol Xinafoate |
94749-08-3 |
Arial; Asmerole; Salmetedur; Serevent Diskus |
β2 Adrenergic Receptor Agonist |
X |
X |
|
|
|
|
| Saracatinib |
379231-04-6 |
AZD 0530; AZD0530 |
Src/Abl Inhibitor |
X |
X |
|
|
|
|
| Sarafloxacin Hydrochloride |
91296-87-6 |
|
Antimicrobial Agent |
X |
|
|
|
|
|
| Saxagliptin |
361442-04-8 |
Onglyza |
DPP-4 Inhibitor; Antidiabetic Agent |
X |
|
|
|
|
|
| SB203580 |
152121-47-6 |
|
p38 MAPK Inhibitor |
X |
|
|
|
|
|
| SB431542 |
301836-41-9 |
|
TGFβR1 Kinase Inhibitor; ALK Inhibitor |
X |
X |
X |
X |
|
|
| SB525334 |
Not Listed |
TGFβ RI Kinase Inhibitor VIII |
TGFβR1 Kinase Inhibitor; ALK Inhibitor |
X |
|
|
|
|
|
| SB939 |
929016-96-6 |
Pracinostat |
HDAC Inhibitor |
X |
|
|
|
|
|
| SC-514 |
354812-17-2 |
|
IKK2 Inhibitor |
X |
|
|
|
|
|
| Scriptaid |
287383-59-9 |
Scriptide |
HDAC Inhibitor |
X |
|
|
|
|
|
| Secukinumab |
1229022-83-6 |
Cosentyx |
IL-17A Inhibitor |
X |
|
|
|
|
|
| Selinexor |
1393477-72-9 |
KPT-330 |
CRM1 Inhibitor |
X |
|
|
|
|
|
| Selnoflast |
2260969-36-4 |
Somalix; RO-7486967; IZD334 |
NLRP3 Inhibitor |
X |
|
|
|
|
|
| Selonsertib |
1448428-04-3 |
|
ASK1 Inhibitor |
X |
X |
|
|
|
|
| Selumetinib |
606143-52-6 |
ARRY-142886; AZD6244 |
MEK Inhibitor |
X |
|
X |
|
|
|
| Semagacestat |
425386-60-3 |
LY450139 |
γ-Secretase Inhibitor |
X |
|
|
|
|
|
| Semaglutide |
910463-68-2 |
|
GLP-1 Analogue |
X |
|
|
|
|
|
| Serotonin |
Not Listed |
5-HT; 5-Hydroxytryptamine; Antemovis; Enteramine |
Monoamine Neurotransmitter |
X |
|
|
|
|
|
| Sertraline |
79617-96-2 |
Zoloft |
SSRI |
X |
|
|
|
|
|
| SGC-CBP30 |
Not Listed |
|
CREBBP/EP300 Bromodomain Inhibitor |
X |
|
X |
|
|
|
| SGC-I-CBP112 |
Not Listed |
|
CBP/p300 Bromodomain Inhibitor |
X |
|
|
|
|
|
| SGI-1776 |
1025065-69-3 |
Pim Kinase Inhibitor IX |
PIM Kinase Inhibitor |
X |
|
|
|
|
|
| Shaoguamycin B |
2738-64-9 |
Piericidin A; Piericidin A1; Piericidine A |
Mitochondrial Inhibitor; NADH Dehydrogenase Inhibitor |
X |
|
|
|
|
|
| Shikonin |
517-89-5 |
C.I. 75535; Isoarnebin 4 |
inhibitor of TMEM16A chloride channel, pyruvate kinase M2, TNF-α, and NF-κB pathway |
X |
|
|
|
|
New – 2025 |
| Sildenafil Citrate |
171599-83-0 |
Viagra |
PDE5 Inhibitor |
X |
X |
|
|
|
|
| Simvastatin |
79902-63-9 |
Zocor |
HMG-CoA Reductase Inhibitor |
X |
X |
|
|
|
|
| Sirolimus |
53123-88-9 |
Rapamycin; AY-22989; NSC 226080 |
mTOR inhibitor |
|
|
|
|
X |
New – 2025 |
| SL 327 |
305350-87-2 |
|
MEK Inhibitor |
X |
|
|
|
|
|
| SLPI |
Not Listed |
Antileukoproteinase; ALK1; ALP; BLPI; HUSI; HUSI-I; MPI; WAP4; WFDC4 |
Peptidase Inhibitor Protein |
|
|
X |
|
|
|
| SNS-314 |
1057249-41-8 |
|
Aurora Kinase Inhibitor |
X |
|
|
|
|
|
| Sodium Hydroxide |
1310-73-2 |
Caustic Soda; Lye; Sodium Hydrate |
Inorganic Compound |
X |
|
|
|
|
|
| Somatostatin 28 |
Not Listed |
Cyclic tetradecapeptide |
Somatostatin Receptor Agonist |
X |
|
|
|
|
|
| Sonidegib |
956697-53-3 |
|
Smoothened (SMO) Inhibitor |
|
X |
|
|
|
|
| Sorafenib Tosylate |
475207-59-1 |
BAY 43-9006; Nexavar; Tosylate Salt |
Multikinase Inhibitor (RAF/VEGFR-2/PDGFRβ) |
X |
X |
X |
|
|
|
| Sotagliflozin |
1018899-04-1 |
Zynquista; LX4211 |
SGLT1/SGLT2 Inhibitor |
X |
|
|
|
|
|
| SP600125 |
129-56-6 |
1,9-Pyrazoloanthrone |
JNK Inhibitor |
X |
|
|
|
|
|
| Sparsentan |
254740-64-2 |
RE-021; DARA-a |
Angiotensin II and endothelin A receptor antagonist |
X |
|
|
|
|
New – 2025 |
| SPD-304 |
Not Listed |
|
TNFα Inhibitor |
X |
|
|
|
|
|
| Sphingosine-1-phosphate |
26993-30-6 |
C18-Sphingosine 1-phosphate; D-erythro-Sphingosine-1-phosphate |
S1P Receptor Agonist |
X |
|
|
|
|
|
| Spiramycin |
8025-81-8 |
Rovamycine |
Antimicrobial Agent |
X |
|
|
|
|
|
| Spironolactone |
52-01-7 |
52-01-7; Aldactone; Spiroctan; Spirolactone; Verospiron |
Aldosterone Inhibitor |
X |
|
|
|
|
|
| SR2211 |
Not Listed |
|
RORγ Inhibitor |
X |
|
|
|
|
|
| SR31747 |
132173-07-0 |
|
Sigma Ligand |
X |
|
|
|
|
|
| SRT2104 |
Not Listed “for BioSeek” |
Sirtuin Modulator |
SIRT1 Activator |
X |
|
|
|
|
|
| ssRNA40 |
Not Listed |
R-1075 |
TLR8 Agonist |
X |
|
|
|
X |
|
| STA 5326 |
541550-19-0 |
Apilimod |
IL-12/IL-23 Inhibitor |
X |
|
|
|
|
|
| Staurosporine |
62996-74-1 |
AM-2282; STS |
Multikinase Inhibitor |
X |
|
X |
X |
|
|
| SU6656 |
330161-87-0 |
|
Src Family Inhibitor |
X |
|
|
|
|
|
| Succinate |
Not Listed |
Succinic Acid |
Chemical Intermediate |
X |
|
|
|
|
|
| Sulfasalazine |
599-79-1 |
Azopyrin; Colo-Pleon; Salazosulfapyridine; Salicylazosulfapyridine; Sulcolon |
Anti-inflammatory Agent |
X |
|
|
|
|
|
| Sulforaphane |
Not Listed |
|
Phytochemical; Antioxidant; Detoxifying Enzyme Inducer |
X |
|
|
|
|
|
| Sunitinib Malate |
341031-54-7 |
SU011248; SU11248; Sutent |
Multikinase Inhibitor (VEGFR2, CSF-1R, PDGFR, SCFR, FLT3, RET) |
X |
X |
X |
|
|
|
| Suzetrigine |
2649467-58-1 |
VX-548 |
NaV1.8 inhibitor that acts as an analgesic, blocker of sodium channel protein |
X |
|
|
|
|
New – 2025 |
| SX-682 |
1648843-04-2 |
|
Allosteric inhibitor of CXCR1 and CXCR2 |
|
|
X |
|
|
New – 2025 |
| Synta66 |
Not Listed |
CLC001531 |
CRAC Channel Inhibitor |
X |
|
|
|
|
|
| T0901317 |
293754-55-9 |
T 0901317 |
LXR Agonist; FXR Agonist |
X |
X |
|
|
|
|
| Tacrolimus |
104987-11-3 |
FK-506; FR900506; NCGC00179232-01 |
Calcineurin Inhibitor; FK506-binding Protein 1A Inhibitor |
X |
|
|
|
X |
|
| Tadalafil |
171596-29-5 |
ADCIRCA; Cialis; Ic351; Tadanafil |
PDE5 Inhibitor |
X |
|
|
|
|
|
| Tafamidis |
594839-88-0 |
|
TTR Stabilizer |
X |
|
|
|
|
|
| Tafenoquine |
106635-81-8 |
Krintafel |
Antimalarial Agent |
X |
|
|
|
|
|
| Talazoparib |
1207456-01-6 |
Talzenna |
PARP Inhibitor |
X |
|
|
X |
|
|
| Tamoxifen |
10540-29-1 |
Genox; Nolvadex; Soltamox; Tamifen |
Estrogen Receptor Modulator |
X |
|
|
|
|
|
| Tanespimycin |
75747-14-7 |
17-AAG |
Hsp90 Inhibitor |
X |
|
X |
|
|
|
| Tapinarof |
79338-84-4 |
WBI-1001; Benvitimod; GSK2894512 |
AhR Agonist |
X |
|
|
|
X |
|
| Taurolithocholic Acid |
6042-32-6 |
|
G Protein-coupled Bile Acid Receptor 1 Agonist |
X |
|
|
|
|
|
| Tavapadon |
1643489-24-0 |
PF-06649751; CVL-751 |
Agonist of dopamine D1/D5 receptor |
X |
|
|
|
|
New – 2025 |
| Tazemetostat |
1403254-99-8 |
EPZ-6438 |
EZH2 inhibitor |
X |
|
|
|
|
New – 2025 |
| Teicoplanin |
61036-62-2 |
Targocid; Ticosin |
Antibiotic Agent |
X |
|
|
|
|
|
| Telaglenastat |
1439399-58-2 |
CB-839 |
GLS1 Inhibitor |
X |
X |
|
|
|
|
| Telbivudine |
3424-98-4 |
Epavudine; Sebivo; Tyzeka |
Antiviral Agent; Thymidine β-L-nucleoside Analogue |
X |
|
|
|
|
|
| Telmisartan |
144701-48-4 |
BIBR 277; Micardis |
Angiotensin II (AT2) Receptor Inhibitor |
X |
X |
|
|
|
|
| Temsirolimus |
162635-04-3 |
CCI 779; Torisel |
FK506-binding Protein 1A (FKBP1A) Inhibitor; mTOR Inhibitor |
X |
|
|
|
|
|
| Tenidap |
120210-48-2 |
9K7CJ74ONH; Tenidapum |
5-Lipoxygenase Inhibitor; COX1/2 Inhibitor |
X |
|
|
|
|
|
| Tepotinib |
1100598-32-0 |
EMD-1214063 |
c-Met Inhibitor |
X |
|
|
|
|
|
| Terbinafine |
91161-71-6 |
Lamasil; Lamisil; Lamisil AT; SF-86-327; Terbinex |
Antimicrobial Agent |
X |
|
|
|
|
|
| Teriflunomide |
108605-62-5 |
A771726; Aubagio; Flucyamide; HMR1726 |
Pyrimidine Synthesis Inhibitor; DHODH Inhibitor |
X |
|
|
|
|
|
| Tetracycline Hydrochloride |
60-54-8 |
Abramycin; Achromycin; Deschlorobiomycin; Tetracyclinum; Tsiklomitsin |
Antibiotic Agent |
X |
|
|
|
|
|
| TGFβ |
Not Listed |
|
TGFβRI/II Agonist |
X |
|
|
|
|
|
| TGFβ2 |
Not Listed |
|
TGFRI, TGFRII Agonist |
X |
|
|
|
|
|
| TGFβ3 |
Not Listed |
|
TGFRI, TGFRII Agonist |
X |
|
|
|
|
|
| TGF-βRI Kinase Inhibitor |
396129-53-6 |
|
TGFβR1 Kinase Inhibitor |
X |
|
|
|
|
|
| TGX-221 |
663619-89-4 |
Tgx 221 |
PI3Kβ Inhibitor |
X |
|
|
|
|
|
| Thapsigargin |
67526-95-8 |
|
SERCA Inhibitor |
X |
X |
|
|
|
|
| Thiostrepton |
1393-48-2 |
Alaninamide; Antibiotic A 8506; Antibiotic X 146; Bryamycin; Thiactin |
Oligopeptide Antibiotic |
X |
|
|
|
|
|
| Tianeptine Sodium |
30123-17-2 |
Coaxil; Stablon; Tatinol |
Tricyclic Antidepressant |
X |
|
|
|
|
|
| Tigecycline |
220620-09-7 |
GAR-936; TBG-MINO; Tygacil; WAY-GAR-936 |
Antibiotic Agent |
X |
|
|
|
|
|
| Tilorone Dihydrochloride |
27591-69-1 |
|
Antiviral Agent; Type I Interferon Inducer |
X |
|
X |
X |
|
|
| Tin Protoporphyrin IX |
14325-05-4 |
NSC 267099 |
Heme Oxygenase Inhibitor |
X |
|
|
|
|
|
| Tin(II) Chloride |
7772-99-8 |
Stannous Chloride; Tin Protochloride; Tin Salt |
Chemical Compound |
X |
|
|
|
|
|
| Tioxolone |
4991-65-5 |
Thioxolone |
Carbonic Anhydrase Inhibitor |
X |
|
|
|
|
|
| Tipiracil HCl |
183204-72-0 |
|
Thymidine Phosphorylase Inhibitor |
|
|
X |
|
|
|
| Tiratricol |
51-24-1 |
Triac |
Thyroid Hormone Analogue; Physiologic Thyroid Hormone |
X |
|
|
|
|
|
| Tivozanib |
475108-18-0 |
AV-951; KRN951 |
VEGFR Inhibitor |
X |
|
|
|
|
|
| TMP-153 |
128831-46-9 |
|
Acetyl-coA Cholesterol Acyltransferase (ACAT) Inhibitor |
X |
|
|
|
|
|
| TNP-470 |
129298-91-5 |
AGM-1470; Agm 1470; DRG-0148 |
Antineoplastic Agent |
X |
|
|
|
|
|
| Tofacitinib |
477600-75-2 |
Tasocitinib; Tofacitinibum; Xeljanz |
JAK1/3 Inhibitor |
X |
X |
X |
|
X |
|
| Topotecan Hydrochloride |
119413-54-6 |
Hycamptamine; Hycamtin; SKF S-104864-A |
TOPO I Inhibitor |
X |
|
X |
|
|
|
| Torcetrapib |
262352-17-0 |
CP 529414; CP-529414 |
CETP Inhibitor |
X |
|
|
|
|
|
| Torin-1 |
1222998-36-8 |
Torin1 |
mTOR Inhibitor |
X |
X |
|
|
|
|
| Torin-2 |
1223001-51-1 |
Torin2 |
mTOR Inhibitor |
X |
X |
|
|
|
|
| Torsemide |
56211-40-6 |
Demadex; TORSEMIDE; Torasemida; Torasemidum |
Diuretic Agent |
X |
|
|
|
|
|
| Tozadenant |
870070-55-6 |
SYN-115 |
Adenosine A2a Receptor Inhibitor |
X |
|
X |
X |
|
|
| Trametinib |
871700-17-3 |
GSK1120212; Mekinist |
MEK Inhibitor |
X |
|
X |
X |
|
|
| Tranexamic Acid |
1197-18-8 |
Cyklokapron; Tranexamsaeure |
Plasminogen Inhibitor |
X |
|
|
|
|
|
| Tranilast |
53902-12-8 |
Rizaben |
Antiallergic Agent |
X |
X |
|
|
|
|
| Trans-Triprolidine |
486-12-4 |
|
Antihistamine Agent |
X |
|
|
|
|
|
| Trastuzumab |
180288-69-1 |
Herceptin; Herclon |
HER2/neu Receptor Inhibitor |
|
|
X |
|
|
|
| Trastuzumab deruxtecan |
1826843-81-5 |
DS-8201; DS-8201a |
Anti-HER2 Drug Conjugate |
X |
|
|
|
|
|
| Treprostinil |
81846-19-7 |
UT-15 |
DP1/EP2 Agonist |
X |
X |
|
|
|
|
| Tretinoin |
302-79-4 |
ATRA; Aberela; Retinoic Acid; Trans-Retinoic Acid; Vitamin A Acid; all-trans-Retinoic Acid |
RAR/RXR Agonist |
X |
|
|
|
|
|
| Triamcinolone |
124-94-7 |
|
Glucocorticoid Receptor (GR) Agonist |
X |
|
|
|
|
|
| Tribanibulin |
897016-82-9 |
Klisyri |
Tubulin Inhibitor |
X |
|
X |
|
|
|
| Trichostatin A |
58880-19-6 |
58880-19-6; TSA; Trichostatin |
HDAC Inhibitor |
X |
|
|
|
|
|
| Triflusal |
322-79-2 |
Aflex; Disgren; Grendis; Triflux |
Platelet Antiaggregant |
X |
|
|
|
|
|
| Trigonelline |
535-83-1 |
Trigenolline |
Nrf2 inhibitor |
X |
|
|
|
|
New – 2025 |
| Trilostane |
13647-35-3 |
13647-35-3; Desopan; Trilostano; Trilostanum; Vetoryl |
3 β-Hydroxysteroid Dehydrogenase Inhibitor |
X |
|
|
|
|
|
| Tropine |
120-29-6 |
3-Tropanol |
Atropine Precursor |
X |
|
|
|
|
|
| Trypan Blue |
72-57-1 |
Direct Blue 14; Membraneblue; TRYPAN BLUE; UNII-I2ZWO3LS3; VisionBlue |
Diazo Dye |
X |
|
|
|
|
|
| Tubastatin A |
1252003-15-8 |
|
HDAC Inhibitor |
X |
|
|
|
|
|
| Tucatinib |
937263-43-9 |
Irbinitinib, ARRY-380, ONT-380 |
Selective HER2 inhibitor |
X |
|
|
|
|
New – 2025 |
| Tunicamycin |
11089-65-9 |
|
Antibiotic Agent |
X |
|
|
|
|
|
| TWEAK |
|
Human TWEAK; TNF-like Weak Inducer; TNFSF12 |
Cytokine |
X |
|
|
|
|
|
| Tyr[SO3H]27)-CCK8 |
25126-32-3 |
C-Terminal Octapeptide of Cholecystokinin (CCK); Kinevac; Sincalide |
Stimulates Pancreatic Secretion |
X |
|
|
|
|
|
| Tyrphostin AG 1296 |
146535-11-7 |
AG-1296 |
PDGFR Inhibitor |
X |
|
|
|
|
|
| U-75302 |
119477-85-9 |
|
Leukotriene B4 (LTB4) Receptor Inhibitor |
X |
|
|
|
|
|
| UK 14, 304 |
Not Listed |
|
α2 Adrenergic Receptor Agonist |
X |
|
|
|
|
|
| Umbralisib |
1532533-67-7 |
TGR-1202; RP5264 |
PI3Kδ/CK1ε Inhibitor |
X |
|
|
|
|
|
| Umifenovir |
131707-25-0 |
|
Antiviral |
X |
X |
|
|
|
|
| UNC0642 |
Not Listed |
|
G9a and GLP Inhibitor |
X |
|
|
|
|
|
| UNC2025 |
1429881-91-3 |
|
Mer Inhibitor; FLT3 Inhibitor |
X |
|
|
|
|
|
| UO126 |
109511-58-2 |
U0126 |
MEK Inhibitor |
X |
|
|
|
|
|
| Upadacitinib |
1310726-60-3 |
ABT-494 |
JAK1 Inhibitor |
X |
|
X |
|
|
|
| Urolithin A |
Not Listed |
|
Microflora Metabolite |
X |
|
|
|
|
|
| Ursodeoxycholic Acid |
128-13-2 |
Actigall; Delursan; Ursodiol; Ursolvan |
Bile Acid |
X |
|
|
|
|
|
| Ursolic Acid |
77-52-1 |
Urson; Malol; Prunol |
Cosmetic Additive |
X |
|
|
|
|
|
| Ustekinumab |
815610-63-0 |
Anti-Human IL-12/IL-23, Human Antibody |
anti-IL-12/IL-23 IgG1κ human monoclonal antibody |
|
|
|
|
|
|
| UTP |
Not Listed |
Uridine triphosphate |
Nucleotide |
X |
|
|
|
|
|
| Vadimezan |
117570-53-3 |
5,6-Mexaa; DMXAA |
DT-Diaphorase Inhibitor |
X |
|
X |
|
|
|
| Valdecoxib |
181695-72-7 |
Bextra |
COX2 Inhibitor |
X |
|
|
|
|
|
| Valinomycin |
2001-95-8 |
|
Antibiotic Agent |
X |
|
|
|
|
|
| Valnemulin Hydrochloride |
133868-46-9 |
|
Pleuromutilin Antibiotic |
X |
|
|
|
|
|
| Valproic Acid |
1069-66-5 |
Depakene; Depakine; Dipropylacetic acid |
HDAC Inhibitor; GABA Transaminase Inhibitor |
X |
X |
|
|
|
|
| Vamorolone |
13209-41-1 |
VBP15 |
dissociative steroidal anti-inflammatory agent and membrane-stabilizer |
X |
|
|
|
|
|
| Vandetanib |
443913-73-3 |
AZD6474; Caprelsa; ZD6474 |
VEGFR2, EGFR Inhibitor |
X |
|
X |
|
|
|
| Vardenafil |
330808-88-3 |
Levitra; Staxyn; Vardenafilum |
PDE5 Inhibitor |
X |
|
|
|
|
|
| Vasopressin |
Not Listed |
ADH; AVP; Antidiuretic Hormone; Argipressin |
Vasopressin Receptor Agonist |
X |
|
|
|
|
|
| Vegetable Extract HI_V19 |
Not Listed |
|
Vegetable Extract |
X |
|
|
|
|
|
| VEGF-165 |
127464-60-2 |
|
VEGF Receptor Agonist |
X |
|
|
|
|
|
| Vemurafenib |
1029872-54-5 |
BRAF(V600E) Kinase Inhibitor; PLX4032; RO5185426; Zelboraf |
BRAF Inhibitor |
X |
|
X |
|
|
|
| Venetoclax |
1257044-40-8 |
ABT199; GDC-0199; Venclexta |
Bcl-2 Inhibitor |
X |
X |
X |
X |
X |
|
| Vepdegestrant |
2229711-68-4 |
ARV-471 |
PROTAC estrogen receptor degrader= |
X |
|
|
|
|
New – 2025 |
| Verapamil |
52-53-9 |
CP-165331; Calan; Covera-hs; Iproveratril; Isoptin; Tarka; Verelan |
L-type Calcium Channel Blocker |
X |
|
|
|
|
|
| Vinblastine |
865-21-4 |
VLB; Vincaleukoblastine |
Microtubule Disruptor |
X |
|
|
|
|
|
| Vincristine Sulfate |
2068-78-2 |
Leurocristine; Vincristin; Vincristina; Vincristine; Vincristinum |
Microtubule Disruptor |
X |
|
|
|
|
|
| Vinorelbine |
71486-22-1 |
Exelbine; Navelbine; UNII-Q6C979R91Y; Vinorelbina; Vinorelbinum |
Microtubule Inhibitor |
X |
|
|
|
|
|
| Vinpocetine |
42971-09-5 |
Apovincaminic Acid Ethyl Ester; Cavinton; TCV-3B |
PDE1 Inhibitor |
X |
|
|
|
|
|
| Vismodegib |
879085-55-9 |
Erivedge; GDC-0449 |
Hedgehog Pathway Inhibitor |
X |
X |
|
X |
|
|
| Vitamin D2 |
50-14-6 |
|
Vitamin D Receptor (VDR) Agonist |
X |
|
|
|
|
|
| VLX1570 |
1431280-51-1 |
|
DUB Inhibitor |
X |
|
|
|
|
|
| Vorasidenib |
1644545-52-7 |
AG-881 |
mIDH1/2 inhibitor |
X |
|
|
|
|
New – 2025 |
| Vorinostat |
149647-78-9 |
SAHA; Suberoylanilide Hydroxamic Acid; Zolinza |
HDAC Inhibitor (HDAC1, HDAC2, HDAC3, HDAC6) |
X |
|
X |
|
|
|
| Voxtalisib |
1123889-87-1 |
PI3K-IN-1; XL765 |
PI3K Inhibitor; mTOR Inhibitor |
X |
|
|
|
|
|
| VX702 |
479543-46-9 |
VX 702 |
p38 MAPK Inhibitor |
X |
|
|
|
|
|
| VZ185 |
2306193-61-1 |
|
BRD7/9 PROTAC Degrader |
X |
|
|
|
|
|
| WKYMVm-NH2 |
Not Listed |
BDBM86297 |
Formyl Peptide Receptor (FPR1, FPR2) Agonist |
X |
|
|
|
|
|
| Wortmannin |
19545-26-7 |
Antibiotic SL-2052; KY 12420; SL-2052; Wartmannin |
PI3Kinase Inhibitor |
X |
|
|
|
|
|
| WS6 |
1421227-53-3 |
|
EBP1/IKK Inhibitor |
X |
|
|
|
|
|
| XAV939 |
284028-89-3 |
|
Tankyrase (TNKS) Inhibitor |
X |
X |
X |
X |
|
|
| XL019 |
945755-56-6 |
|
JAK2 Inhibitor |
X |
|
|
|
|
|
| XL147 |
956958-53-5 |
PI3K Inhibitor X; Pilaralisib |
PI3K Inhibitor |
X |
|
|
|
|
|
| XL880 |
849217-64-7 |
EXEL-2880; Foretinib; GSK089; GSK1363089; XL-880 |
VEGFR2 Inhibitor |
X |
X |
X |
X |
|
|
| Y27632 |
146986-50-7 |
|
ROCK1, ROCK2 Inhibitor |
X |
X |
|
|
|
|
| YM155 |
781661-94-7 |
|
Survivin Inhibitor |
X |
|
|
|
|
|
| YM201636 |
371942-69-7 |
|
PIKfyve Inhibitor |
X |
|
|
|
|
|
| Zaprinast |
37762-06-4 |
|
PDE5/PDE6/PDE9 Inhibitor |
X |
|
|
|
|
|
| Zegocractin |
1713240-67-5 |
CM-4620 |
CRAC Inhibitor |
X |
X |
|
|
|
|
| Zetomipzomib |
1629677-75-3 |
KZR-616 |
Immunoproteasome Inhibitor |
X |
|
|
|
|
|
| Zinc Chloride |
7646-85-7 |
|
Chemical Compound |
X |
|
|
|
|
|
| Zinc Protoporphyrin IX |
15442-64-5 |
ZPP |
Heme Oxygenase Inhibitor |
X |
|
|
|
|
|
| Ziprasidone Hydrochloride |
122883-93-6 |
Zeldox; Ziprasidone |
Antipsychotic Agent |
X |
|
|
|
|
|
| Ziritaxestat |
1628260-79-6 |
GLPG1690 |
Autotaxin Inhibitor |
X |
X |
|
|
|
|
| ZM39923 |
273727-89-2 |
|
JAK3 Inhibitor |
X |
|
|
|
|
|
| ZM449829 |
4452-06-6 |
|
JAK3 Inhibitor |
X |
|
|
|
|
|
| Zoldonrasib |
2922732-54-3 |
RMC-9805 |
2nd generation K-Ras Inhibitor |
X |
|
|
|
|
New – 2025 |
| Zongertinib |
2728667-27-2 |
BI 1810631 |
HER2 and EGFR tyrosine kinase inhibitor |
X |
|
|
|
|
New – 2025 |
| Zunsemetinib |
1640282-42-3 |
ATI-450; CDD-450 |
MK2 Inhibitor |
X |
|
|
|
|
|
| α-Amanitin |
23109-05-9 |
Alpha-Amanitine; Alpha-Amatoxin; HSDB 3458 |
RNA Polymerase II Inhibitor |
X |
|
|
|
|
|